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Abstract 
Comparative Modeling and Functional Characterization of Two Enzymes of the 
Cyclooxygenase Pathway in Drosophila melanogaster 
by 
Yan Qi 
 
Mentor: Shaneen Singh 
Eicosanoids are biologically active molecules oxygenated from twenty carbon 
polyunsaturated fatty acids. Natural eicosanoids exert potent biological effects in humans, 
and a great deal of pharmaceutical research has led to the discovery of compounds for 
selective inhibition of specific enzymes in eicosanoid biosynthesis.  Coupled with 
different receptors, eicosanoids mediate various physiological and pathophysiological 
processes, including fever generation, pain response, vasoconstriction, vasodilation, 
platelet aggregation, platelet declumping, body temperature maintenance and sleep-wake 
cycle regulation. In mammals, the eicosanoid biosynthesis has three pathways: the 
cyclooxygenase (COX) pathway, the lipoxygenase (LOX) pathway and the epoxygenase 
pathway. The COX pathway synthesizes prostanoids, which are important signaling 
molecules in inflammation.  Because of their central role in inflammatory disease and 
human health, COX enzymes continue to be a focus of intense research as new details 
emerge about their mechanism of action and their interactions with NSAIDs. 
 To date, the majority of studies dealing with the COX pathway are centered on 
mammalian systems. Although the literature is rich in speculations that prostaglandins are 
central signaling molecules for mediating and coordinating insect cellular immunity, 
	  v	  
genes responsible for encoding COX or COX-like enzymes and other enzymes in the 
COX pathway have not been reported in insects.  The value of Drosophila melanogaster 
as a model organism is well established, and the fundamental regulatory signaling 
mechanisms that regulate immunity at the cellular level in human and flies are conserved. 
 Given the importance of eicosanoids in mammalian and insect immunity, this 
study was designed to identify and characterize the enzymes that mediate eicosanoid 
biosynthesis in D. melanogaster computationally. After a preliminary extensive search 
for putative D. melanogaster homologues for all enzymes in the COX pathway, we 
conducted a systematic, comprehensive, and detailed computational investigation for two 
enzymes, COX and prostaglandin E synthase (PGES) in an endeavor to model and 
characterize the possible candidates and identify those that possess all the requisite 
sequence and structural motifs to qualify as valid COX(s)/PGE synthase proteins. In this 
study, we report the presence of qualified D. melanogaster COX(s)/PGE synthase 
proteins, characterize their biophysical properties, and compare them with their 
mammalian counterparts. This study lays the groundwork for further exploration of these 
proteins and establishing their role in D. melanogaster inflammation and immunity, 
opening up avenues for addressing the use of this model organism in COX signaling and 
its crosstalk with other signaling pathways. 
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Chapter 1 Introduction 
The eicosanoid biosynthetic pathway 
Eicosanoids are biologically active, oxygenated metabolites of twenty carbon 
polyunsaturated fatty acids that contain three to five cis, methylene-interrupted double 
bonds and play key roles in various physiological processes such as reproduction, 
immunity and inflammation, ion transport and various other signaling pathways 
(Buczynski, Dumlao, and Dennis 2009). Coupled with different receptors, eicosanoids 
mediate various biological processes, some examples of which are vasoconstriction, 
vasodilation, platelet aggregation, platelet declumping, bone resorption, fever generation 
and maturation of oocytes for ovulation (David W. Stanley-Samuelson 1987; Colin D. 
Funk 2001). In mammals, the C20 fatty acid substrates from which eicosanoids are 
derived include members from omega-3, omega-6 and omega-9 family of essential 
polyunsaturated fatty acids (William L Smith 1989; Lands and Samuelsson 1968; 
Needleman et al. 1979).  
Mammalian eicosanoid biosynthetic pathway has three branches: (1) the 
cyclooxygenase (COX) pathway, which synthesizes prostanoids (prostaglandins (PGs) 
and thromboxanes (TXs)); (2) the lipoxygenase (LOX) pathway, which produces 
leukotrienes and mono-, di- and tri-hydroxy acids; and (3) cytochrome P-450 
epoxygenase pathway, which generates epoxides (Buczynski, Dumlao, and Dennis 
2009) (figure 1). 
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Figure 1.  Eicosanoid biosynthetic pathway in mammals. Enzymes of COX pathway, 
LOX pathway and epoxygenase pathway are colored in grey, blue and violet, 
respectively.   
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COX Pathway 
The products synthesized by the COX pathway are called prostanoids, which are 
important signaling molecules in inflammation. The COX pathway enzymes synthesize 
two types of prostanoids, PGs and TXs, both of which are short-lived signaling lipid 
molecules (Colin D. Funk 2001). The most common products from the COX pathway 
are the 2-series compounds, such as prostaglandin H2 (PGH2) and thromboxane-A2 
(TxA2). The “2” indicates the number of carbon-carbon double bonds in the compounds 
(William L Smith, Urade, and Jakobsson 2011). PGH2 is synthesized from arachidonic 
acid by the enzyme COX (also known as PGH2 synthase; EC 1.14.99.1) in the first 
committed step of the pathway (W L Smith and Murphy 2002). Biologically active 
prostanoids, which include PGD2, PGE2, PGF2α, PGI2 and TxA2, are biosynthesized 
from PGH2 in a cell type-dependent manner through enzymatic reactions (W L Smith 
1989). Even though formation of monohydroxy fatty acids has been observed during 
reactions catalyzed by prostaglandin H synthase, they do not seem to be of physiological 
significance (Serhan, Chiang, and Van Dyke 2008; Sharma et al. 2010; Groeger et al. 
2010). The mechanism of prostanoid action is well established in various mammalian 
cell types and primarily involves signaling via G-protein-coupled receptors (Negishi, 
Sugimoto, and Ichikawa 1995; Gerlo et al. 2004).  
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Prostaglandin E2 (PGE2) 
PGE2, also called dinoprostone, is the best-studied prostanoid. Since PGE2 was 
initially isolated from human seminal plasma in 1963 (Samuelsson 1963), more than 
32,000 PGE2  related articles have been indexed in PubMed till October 2013. PGE2 is 
expressed in many different cells, including fibroblasts, macrophages and a series of 
malignant cells (Harris et al. 2002, 2). PGE2 is involved in numerous physiological and 
pathophysiological processes, including sleep-wake cycle, maintenance of body 
temperature (Legler et al. 2010), cancer, arthritis, pain response (Harris et al. 2002; 
Colin D. Funk 2001), bronchodilation (Park, Pillinger, and Abramson 2006; Simmons, 
Botting, and Hla 2004), inhibition of apoptosis in tumor cells, and alteration of 
malignant tumor cells’ morphology (Sumitani et al. 2001; Gately 2000; Jakobsson et al. 
1999). The conversion of PGH2 into PGE2 is carried out by prostaglandin E synthase, 
which includes three structurally distinct prostaglandin E synthases (PGES; EC 
5.3.99.3): microsomal prostaglandin E synthase-1, microsomal prostaglandin E 
synthase-2 and cytosolic prostaglandin E synthase. 
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Prostaglandin D2 (PGD2) 
PGD2 is a structural isomer of PGE2. PGE2 has a 9-keto and 11-hydroxy moiety, 
while PGD2 has a 9-hydroxy and 11-keto moiety (Buczynski, Dumlao, and Dennis 
2009). PGD2 is the most abundant PG in the central nervous system in mammals 
(Narumiya et al. 1982), and is involved in sleep regulation, pain response, and 
hypothermia (Hayaishi et al. 2004; Hayaishi 1991). The biosynthesis of PGD2 from 
PGH2 is catalyzed by two structurally divergent prostaglandin D2 synthases, 
hematopoietic prostaglandin D2 synthase (HPGDS; EC 5.3.99.2) and prostaglandin D2 
synthase (PGDS; EC 5.3.99.2), that are differentially expressed in different organs 
(William L Smith, Urade, and Jakobsson 2011).  
Prostaglandin F2α (PGF2α) 
PGF2α was also first isolated from human seminal fluid (Samuelsson 1963), and 
affects multiple biological processes, including embryo development, vasoconstriction 
and acute inflammation (Basu 2007). PGF2α can be synthesized from different 
substrates: (a) from PGE2 by two structurally diverse carbonyl reductases (CBR1 and 
CBR2; EC 1.1.1.184, EC 1.1.1.189), (b) from PGH2 by PGF2 synthase (EC 1.1.1.188), 
and (c) an isomer of PGF2α, 9α, 11β-PGF2α can be synthesized from PGD2, by PGD2 11-
ketoreductase (EC 1.1.1.188).   
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Prostaglandin I2/prostacyclin (PGI2) 
Prostaglandin I2, also known as prostacyclin, is a strong platelet aggregation 
inhibitor, and causes vasodilation and anti-platelet aggregation (Tateson, Moncada, and 
Vane 1977). PGI2 is synthesized from PGH2 by prostacyclin synthase (PGIS; 
EC5.3.99.4), which is a member of the cytochrome P450 superfamily. 
Thromboxane A2 (TxA2) 
TxA2 was first identified in 1975 (Hamberg, Svensson, and Samuelsson 1975), 
and has an opposing function from that of PGI2. TxA2 causes vasoconstriction and 
platelet aggregation. TxA2 is derived from PGH2 by the enzyme thromboxane-A 
synthase (TBXAS1; EC 5.3.99.5), another member of the cytochrome P450 superfamily. 
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LOX pathway  
Lipoxygenase (LOX; EC 1.13.11.12) belongs to a large family of non-heme iron 
containing fatty acid dioxygenases and is found to exist widely in various taxonomic 
divisions including fungi, plant and animals (Brash 1999; Grechkin 1998; Gerwick 
1994; C D Funk 1996; S. Yamamoto, Suzuki, and Ueda 1997). LOXs have been linked 
with various biological functions and signaling pathways (Feussner and Wasternack 
2002). LOXs are known to mediate peroxidation reactions and mobilization of lipids 
(Brash 1999), synthesize signaling molecules that provoke bronchoconstriction and 
inflammation, and catalyze oxygenation of polyunsaturated fatty acids (PUFAs) in 
plants during the process of germination in oil-seed plants (Andreou, Brodhun, and 
Feussner 2009).   
LOX enzymes can use polyunsaturated fatty acids that contain multiple cis 
double bonds as substrates, for example, linoleic acid (LA), α-linolenic acid (α-LeA) or 
arachidonic acid (AA), and yield hydroperoxy derivatives of PUFAs. Lack of the 
necessary substrates in bacteria and yeast is mirrored by the absence of these enzymes in 
Saccharomyces cerevisiae and prokaryote genomes. Organisms lower down on the 
evolutionary scale, such as the unicellular organism Chlorella have only one gene that 
codes for a lipoxygenase (Zimmerman and Vick 1973), but higher plants and animals 
seem to possess more than one lipoxygenase. For example, multiple lipoxygenases have 
been identified in Glycine max (soybean) (Christopher and Axelrod 1971), seven 
lipoxygenase coding genes have been established in mice and five lipoxygenases genes 
in human (Krieg et al. 1998; Boeglin, Kim, and Brash 1998). Very little is known about 
lipoxygenases in insects, although hydroxyeicosatetraenoic acid (HETE), which is a 
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typical lipoxygenase product, has been identified in the primitive insect Thermobia 
domestica (Gadelhak, Pedibhotla, and Stanley-Samuelson 1995). 
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Epoxygenase pathway 
In contrast to the extensively studied COX and LOX pathways, little is known 
about the epoxygenase pathway. In this pathway, cytochrome P450 (CYP450) 
epoxygenases use arachidonic acid as substrate and produce epoxyeicosatrienoic acids 
(EET), which function as autocrine and paracrine lipid mediators. Epoxygenase inserts 
an oxygen atom on a carbon that is attached to one of the double bonds of arachidonic 
acid. Arachidonic acid has four double bonds, and epoxidation can occur at any of the 
four bonds, resulting in the production of four regioisomers: 5,6-, 8,9-, 11,12- and 14,15-
EETs, each of which can have either R, S or the S, R enantiomer (Zeldin 2001). Even 
though different EET regioisomers have quantitative or qualitative differences in various 
reactions, they have similar metabolic properties, so EETs are considered a single class 
of molecules (Spector 2008). EETs are involved in secretion of hormone peptides 
(Cashman, Hanks, and Weiner 1987; Falck et al. 1983; Snyder, Yadagiri, and Falck 
1989), regulation of inflammation (Node et al. 1999) and homeostasis (Node et al. 2001). 
EETs are converted to less active diols dihydroxyeicosatetraenoic acids (DHETs) by 
soluble epoxide hydrolase (sEH) (Spector 2008; Elmarakby 2012). Till date, the 
functions of DHETs have not been elaborated (Elmarakby 2012). Although prevalent in 
mammals and other vertebrates including fish (Oleksiak et al. 2003), an enzyme with 
homology to cytochrome P450 epoxygenase has not been detected in insect genomes (D. 
Stanley 2011). 
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Eicosanoids in insects 
Eicosanoids have primarily been linked with immunity and inflammation in 
insects (David Stanley, Haas, and Miller 2012). Insects possess three lines of defense to 
protect themselves from infections and invasive threats: (a) a physical barrier made up 
of cuticle and peritrophic membrane (David Stanley, Miller, and Tunaz 2009), (b) 
humoral response, which includes synthesis of antimicrobial peptides, the bacteriolytic 
enzyme lysozyme and activation of the prophenoloxidase (PPO) system (Kanost, Jiang, 
and Yu 2004), and (c) hemocyte-mediated cellular response, which includes three 
physiological processes: phagocytosis, nodulation and encapsulation (Strand 2008). 
Eicosanoids have been implicated as important mediators of insect immune response in 
multiple types of cellular defense responses, such as phagocytosis, microaggregation, 
nodulation, encapsulation, cell spreading and hemocyte migration toward bacterial 
peptides.   
Eicosanoids are present and modulated during infection in insect immune tissues, 
and the presence of PGs has been established with full mass spectra of PGs (David 
Stanley 2006) in insect  immune tissues, hemocytes and fat body (Gadelhak, Pedibhotla, 
and Stanley-Samuelson 1995). Multiple research studies showed that in insects, 
eicosanoids mediate immune reactions against different types of invaders, e.g., fungi, 
protozoan, virus, bacteria and parasitoids (Dean et al. 2002; Garcia, Machado, and 
Azambuja 2004; Carton et al. 2002). Stanley-Samuelson et al. and Miller et al.’s 
experiments show that eicosanoids mediate insect nodulation in response to bacterial 
invasions (D W Stanley-Samuelson et al. 1991; Miller, Nguyen, and Stanley-Samuelson 
1994), and Downer et al. have suggested that eicosanoids play roles in three separate 
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cellular processes: phagocytosis, cell spreading and PPO activation in wax moths, 
Galleria mellonella (Downer et al. 1997). Morishima et al. suggest that eicosanoids 
mediate induction of cecropin and lysozyme in fat body of the silkworm, Bombyx mori 
(Morishima et al. 1997). Recent studies indicate that the D. melanogaster pxt 
(Peroxinectin-like) may be a gene encoding an insect COX, and this has opened up new 
avenues for experimentation and investigation in immune signaling in D. melanogaster 
(Tootle and Spradling 2008).   
In addition to immune tissues and cells, PGs or PG biosynthesis have been 
detected in cricket reproductive tissues (D. Stanley-Samuelson and Loher 1986), tobacco 
hornworm midgut (Büyükgüzel et al. 2002), and reproductive tissues of D. 
melanogaster (David Stanley 2006; Tootle and Spradling 2008; David Stanley, Miller, 
and Tunaz 2009; Toolson et al. 1994). Prostaglandins are thought to be involved in 
thermoregulation, control of hatching, egg-laying, and oogenesis in insects (David 
Stanley 2006; Tootle and Spradling 2008). All these studies strongly argue for 
significant conservation in eicosanoids biosynthesis and function in insects.  
Although the literature is rich in speculations that prostaglandins are central 
signaling molecules for mediating and coordinating insect cellular immunity, genes 
responsible for encoding COX or COX-like enzymes have not been reported in insects. 
Most work on insect systems has focused on COX products, the prostaglandins and the 
eicosanoid hypothesis has been supported by experiments with a phylogenetically wide 
range of insect species, and a wide range of infecting agents, and several specific 
eicosanoid-mediated cellular actions have been identified in the process (David Stanley, 
Miller, and Tunaz 2009). In biochemical research on PG actions, the influence of PGs 
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on gene expression in insect cells has been recorded, linking PG actions to specific 
proteins (Morishima et al. 1997). Effects of aspirin and other NSAIDs on PG synthesis 
have also been reported for insects. Machado et al. found that cultured ovarioles treated 
with aspirin and other PG synthesis inhibitors have decreased choriogenesis, which can 
be reversed by PGF2α (Machado et al. 2007). However, the mechanism of eicosanoid 
actions in insects is still not very well understood. 
Specifically in D. melanogaster, Pxt, also known as Chorion peroxidase, a 
peroxidase with a clear role in reproduction has been suggested to function like a COX 
(Tootle and Spradling 2008; Vázquez, Rodríguez, and Zurita 2002): a pxt mutant causes 
infertility in D. melanogaster female, similar to COX-2 mutant mice and sterile pxt 
mutant D. melanogaster females can be rescued by mouse COX-1 (Tootle and Spradling 
2008). Unpublished studies show a role of Pxt in immune function in D. melanogaster 
as well (personal communication, Dr. Shubha Govind).   
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Cyclooxygenase 
COXs or prostaglandin H synthases (PGHS) are heme-containing peroxidase 
enzymes responsible for the biosynthesis of a family of eicosanoids and are key players 
in inflammation and immunity (W L Smith, Garavito, and DeWitt 1996). COX is the 
rate-limiting key enzyme of prostaglandin synthesis, and COX enzymes are known to be 
targets of various non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin 
(Vane 1971). Therefore, COX and the COX pathway have been the subjects of active 
research in academic and pharmaceutical studies.  
COXs belong to the superfamily of animal heme peroxidases, which contains a 
large group of ubiquitous enzymes that catalyze the oxidation reaction of various 
substrates by hydrogen peroxide or organic hydroperoxide and usually contain a heme 
prosthetic group in their active site (Dunford 1999). COXs are unique amongst this 
group in possessing the capability to carry out two enzymatic activities: cyclooxygenase 
activity and peroxidase activity (Garavito and Mulichak 2003). COXs catalyze the 
committed step leading to the synthesis of prostaglandins, thromboxane, and 
prostacyclin (W L Smith, Garavito, and DeWitt 1996; Marnett et al. 1999).  
Peroxidase (POX) and cyclooxygenase (COX) activities of COX enzymes are 
structurally distinct but functionally connected (W L Smith, DeWitt, and Garavito 
2000). In the POX reaction, Compound I is formed by oxidation of the Fe3+ 
protoporphyrin IX (PPIX) into an oxyferryl heme porphyrin π-cation radical (Schulz et 
al. 1984; Patterson, Poulos, and Goodin 1995). Then Compound I receives an electron 
from Tyr385 through an intramolecular reduction, resulting in the formation of a tyrosyl 
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radical (Karthein et al. 1988; Dietz, Nastainczyk, and Ruf 1988), which is known as 
intermediate II. Intermediate II is the COX active form of this enzyme. In the COX 
reaction, the Tyr385 radical removes a hydrogen atom from C-13 of the substrate 
arachidonic acid to trigger the COX reaction (Benecky et al. 1993) and converts 
arachidonic acid into Prostaglandin G2. The POX activity reduces PGG2 into PGH2. The 
POX activity is not dependent on the COX activity, so when the COX site is occupied 
by an inhibitor such as an NSAID, the POX activity can operate independently (Mizuno, 
Yamamoto, and Lands 1982). On the contrary, the COX activity is dependent on the 
POX activity because the generation of the tyrosyl radical of the COX activity requires 
the heme group, which is located at the POX site (W L Smith and Lands 1972; Landino 
et al. 1997).  
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Figure 2.  Mechanism of COX catalysis. Tyrosyl radical Tyr385, which is required for the 
COX reaction, is generated by the POX reaction. (Reprint of figure 3, (van der Donk, Tsai, and 
Kulmacz 2002)) 
There are two types of cyclooxygenases present in mammals: COX-1 and COX-
2. COX-1 is a housekeeping enzyme, while COX-2 is an inducible enzyme (W L Smith, 
Garavito, and DeWitt 1996; Marnett et al. 1999). COX-1 is expressed constitutively in 
most tissues and systems, but COX-2 is induced by different factors, including growth 
factors and tumor promoters, to express rapidly and differentially in various cell types 
(W L Smith, Garavito, and DeWitt 1996). The COX-1 gene is known to regulate 
angiogenesis in endothelial cells and immune response (Tsujii et al. 1998; Rocca et al. 
1999). Inducible expression of COX-2 is thought to be important for reproduction (Lim 
et al. 1999; Lim et al. 1997), immune response (Rocca et al. 1999), development 
	  16	  
(Gilbert et al. 1994; Xie et al. 1991; T. Endo et al. 1995), kidney function (H. F. Cheng 
et al. 1999), liver function (Ledwith et al. 1997; Kraemer et al. 1996), neurotransmission 
(Breder, Dewitt, and Kraig 1995), bone formation regulation (Pilbeam et al. 1997; 
Pilbeam et al. 1993), muscle function (Pritchard et al. 1994; Rimarachin et al. 1994) and 
pancreatic regulation (Robertson 1998).  
Separate genes encode COX-1 and COX-2, but the two genes share high 
sequence similarity (60% amino acid sequence similarity) and highly similar structural 
folds, as well as similar catalytic mechanisms (Järving et al. 2004). Mammalian COXs 
have been well studied, and several aspects of their structural folds and functional 
properties have been resolved based on experimental data (W L Smith, DeWitt, and 
Garavito 2000) and the solved structures of both COX-1 and -2 (Picot, Loll, and 
Garavito 1994; Kurumbail et al. 1996). Both COX-1 and COX-2 are thought to be 
membrane bound because both of them have a membrane-binding domain (MBD) (Otto 
and Smith 1996; A G Spencer et al. 1999). However, antibody staining experiments 
reveal that their sub-cellular localization varies from cytoplasmic to inner and outer 
membrane of the nuclear envelope, Golgi apparatus, lysosome, or the lumenal surface of 
the endoplasmic reticulum, depending on physiological conditions (Koumas and Phipps 
2002; García-Bueno, Serrats, and Sawchenko 2009; Leclerc et al. 2008).  
Both enzymes function as homodimers (Yuan et al. 2006), with each monomer 
composed of an EGF-like domain, a membrane-binding domain (MBD) and a catalytic 
animal heme peroxidase domain (W L Smith, DeWitt, and Garavito 2000). The core 
structures of the catalytic domain of COX-1 and COX-2 adopt nearly identical folds: the 
root mean square deviation (RMSD) of sheep COX-1 (PDB ID: 1CQE) and mouse 
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COX-2 (PDB ID: 1CVU) is only 0.4 Å (Tsai and Kulmacz 2010; W L Smith, DeWitt, 
and Garavito 2000). In both COX-1 and COX-2, functionally important residues include 
Arg120, Gln203, His207, Val349, His388, Tyr385, and Ser530 (W L Smith, DeWitt, 
and Garavito 2000; Loll, Picot, and Garavito 1995) (Figure 3). Arg120 contacts C-1 of 
the substrate arachidonic acid. Gln203, His 207, His 388 are crucial for the peroxidase 
activity, while Tyr385 is essential for the cyclooxygenase activity. The catalytic pocket 
of mammalian COX, with His207, Tyr385, and His388, is L-shaped and largely 
hydrophobic (W L Smith, DeWitt, and Garavito 2000). The acetylation of Ser530 (Loll, 
Picot, and Garavito 1995) is the structural basis of aspirin inhibition of COXs (Garscha 
and Oliw 2009).  
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Figure 3. Structure of arachidonic acid bound to Sheep COX-1 (PDB ID: 1DIY) showing 
the location of the important residues. COX-1 structure is rendered in cartoon, residues 120, 
203, 207, 349, 385, 388 and 530, cofactor protoporphyrin IX containing Co, and substrate 
arachidonic acid are rendered in sticks. Glu203, His207 and His388 are shown in orange. Tyr385 
is shown in blue. Val347 is colored in yellow. Arg120 is colored in light pink. Ser530 is colored 
in purple. Rendering of the structure and distance between Tyr385 and C-13 of arachidonic was 
calculated using the program Pymol. 
Despite extensive literature on mammalian COXs, several important questions 
remain regarding their in vivo biochemical functions. For example, recent studies have 
shown that even though COXs are pro-inflammatory, COX-2 can mediate the 
biosynthesis of anti-inflammatory electrophilic fatty acid exo-derivatives (EFOXs) 
(Groeger et al. 2010). Such studies underscore the need for a deeper understanding of 
structure-function relationships of these complex enzymes. 
  A phylogenetic analysis of peroxidases across the evolutionary scale shows that 
this superfamily can be divided into seven categories: chordate peroxidases, ecdysozoan 
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and deuterostomian peroxidasins, ecdysozoan and echinozoan peroxinectins, prokaryotic 
and eukaryotic cyclooxygenases, bacterial peroxicins, peroxidockerins, ecdysozoan and 
deuterostomian dual oxidases (Zamocky et al. 2008). Despite low conservation of 
primary structure, COX enzymes from fungi are able to catalyze the conversion of 
arachidonic acid to PGH2 (Garscha and Oliw 2009). Mammalian COX-1 and COX-2 are 
highly conserved in primary structure with sequence identity of paralogues ranging from 
60-65%, and orthologues from 85-90% (W L Smith, DeWitt, and Garavito 2000). 
However, more distant COX genes do exist in the genomes of lower vertebrates 
(Ishikawa et al. 2007), invertebrates (Koljak et al. 2001; Varvas et al. 1999),  fungi (Lee 
et al. 2008), and plants (Lee et al. 2008) (table 1). Characterization of marine 
invertebrate COX genes points to independent duplication events in vertebrate and 
invertebrate lineages (Järving et al. 2004). Insects are known to synthesize 
prostaglandins (D W Stanley-Samuelson and Ogg 1994; Bowman, Dillwith, and Sauer 
1996), but the enzymes for their biosynthesis have not even been clearly identified. The 
presence of COX enzyme(s) in insects in general and D. melanogaster in particular 
remains debatable. In D. melanogaster, protein peroxinectin-like (Pxt) discovered in 
2002 (Vázquez, Rodríguez, and Zurita 2002), is the only known putative COX-like 
enzyme and is important in oogenesis and eggshell production (Tootle and Spradling 
2008; Tootle et al. 2011). 
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Table 1. Species with known cyclooxygenases 
Species (common name/category) KEGG ID 
Homo sapiens (human) HSA: 5742(PTGS1) 5743(PTGS2) 
Pan troglodytes (chimpanzee) PTR: 464713(PTGS1) 469616(PTGS2) 
Macaca mulatta (rhesus monkey) MCC: 698213(PTGS1) 716671(PTGS2) 
Mus musculus (mouse) MMU: 19224(Ptgs1) 19225(Ptgs2) 
Rattus norvegicus (Norway rat) RNO: 24693(Ptgs1) 29527(Ptgs2) 
Canis lupus familiaris (dog) CFA: 403544(PTGS1) 442942(PTGS2) 
Bos taurus (cow) BTA: 282022(PTGS1) 282023(PTGS2) 
Sus scrofa (pig) SSC: 397541(PTGS1) 397590(PGHS-2) 
Equus caballus (horse) ECB: 100034087(PTGS1) 791253(PTGS
2) 
Monodelphis domestica (opossum) MDO: 100016747 100024802 
Ornithorhynchus anatinus (platypus) OAA: 100081492 100086096 
Gallus gallus (chicken) GGA: 396451(PTGS2) 427752(PTGS1) 
Taeniopygia guttata (zebra finch) TGU: 100221909 100226968 
Xenopus laevis (African clawed frog) XLA: 100037245(ptgs1) 446781(ptgs2) 
Xenopus (Silurana) tropicalis (western 
clawed frog)  
XTR: 595089(ptgs2) 
Danio rerio (zebrafish) DRE: 246226(ptgs1) 246227(ptgs2a) 559
020(ptgs2b) 
Branchiostoma floridae (Florida lancelet) BFO: BRAFLDRAFT_129952 
Ciona intestinalis (sea squirt) CIN: 100183010 100183175 
Podospora anserina (fungus) PAN: PODANSg1229 
Magnaporthe grisea (fungus) MGR: MGG_10859 
Aspergillus nidulans (fungus) ANI: AN5028.2 
Aspergillus fumigatus (fungus) AFM: AFUA_3G12120 
Aspergillus oryzae (fungus) AOR: AO090003000772 
Aspergillu niger (fungus) ANG: An02g07930 
Aspergillus flavus (fungus) AFV: AFLA_030430 
Aspergillus clavatus (fungus) ACT: ACLA_039980 
Penicillium chrysogenum (fungus) PCS: Pc18g00240 
	  21	  
Neosartorya fischeri (fungus) NFI: NFIA_065200 
Coccidioides immitis (fungus) CIM: CIMG_00042 
Uncinocarpus reesii (fungus) URE: UREG_00168 
Postia placenta (fungus) PPL: POSPLDRAFT_98495 
Laccaria bicolor (fungus) LBC: LACBIDRAFT_315146 
Ustilago maydis (fungus) UMA: UM04571.1 
Nitrosomonas europaea (bacteria) NEU: NE1240  
Methylobacterium sp. 4-46 (bacteria) MET: M446_1624 
Methylobacterium nodulans (bacteria) MNO: Mnod_6498 
Rhodobacter sphaeroides (bacteria) RSH: Rsph17029_3626 
Rhodobacter sphaeroides (bacteria) RSK: RSKD131_4262 
Roseobacter denitrificans (bacteria) RDE: RD1_1072 
Mycobacterium vanbaalenii (bacteria) MVA: Mvan_3099 
Streptosporangium roseum (bacteria) SRO: Sros_8745 
Gymnopilus obscurus (bacteria) GOB: Gobs_1219 
Nostoc punctiforme (bacteria) NPU: Npun_R5469  
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Prostaglandin E synthase 
Prostaglandin E synthases (PGES) are isomerases that catalyze the conversion of 
PGH2 to PGE2. These enzymes are unique because the same catalytic activity is 
manifested through three structurally distinct PGESs (M Murakami et al. 2000).  
There are three PGESs: PGES-1, PGES-2 and PGES3. PGES-1 and PGES-2 are 
microsomal proteins that are also known as mPGES-1 and mPGES-2, while PGES-3 is a 
cytosolic protein, and also known as cPGES (T Tanioka et al. 2000). The two 
membrane-associated prostaglandin E synthases, PGES-1 and PGES-2, are inducible by 
inflammation, and can be down regulated by anti-inflammatory glucocorticoids; on the 
other hand, cytosolic PGES-3 is constitutively expressed (Toshihiro Tanioka et al. 2003; 
Weaver et al. 2000). Activity of both PGES-1 and PGES-3 is glutathione (GSH)-
dependent, and PGES-2 requires the cofactor thiol for enzymatic activity. PGES-1 is co-
expressed with and functionally linked to COX-2. PGES-3 is co-expressed with and 
functionally linked to with COX-1 (M Murakami et al. 2000). PGES-2 does not have a 
preference to couple with COX-1 or COX-2, and it can couple with either to produce 
PGE2 (Makoto Murakami et al. 2003)(figure4).   
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Figure 4. Coupling of COX-1/2 with PGES-1, PGES-2 and PGES-3 
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Prostaglandin E synthase-1 (PGES-1/mPGES-1) 
Prostaglandin E Synthase-1 (PGES-1), also known as microsomal prostaglandin 
E synthase-1 (mPGES-1), is an inducible membrane-bound enzyme that catalyzes the 
isomerization of the pro-inflammatory molecule PGE2 from PGH2. Because of its 
importance in inflammation, PGES-1 is a potential and promising target for drugs in 
many diseases, including a variety of cancers (Nakanishi et al. 2010; Rådmark and 
Samuelsson 2010). Expression level of PGES-1 was found to be very low in normal rat 
tissues, and PGES-1 expression level is significantly induced by a stimuli of 
lipopolysaccharide or endotoxin in various tissues, including lung, brain, heart, testis, 
colon, spleen, and seminal vesicle tissues (Mancini et al. 1995; Yamagata et al. 2001). 
 The PGES-1 protein sequence contains approximately 150 amino acids and 
belongs to the MAPGE (membrane-associated proteins involved in eicosanoid and 
glutathione metabolism) superfamily. The MAPGE superfamily includes microsomal 
glutathione transferase-1 (MGST-1), MGST-2, MGST-3, FLAP and leukotriene C4 
synthase (LTCS). Like most proteins in MAPGE family, PGES-1 functions using 
glutathione as a co-factor. Jegerschold et al. solved the first crystal structure of PGES-1 
in 2008 using recombinant human PGES-1 expressed in E. coli with EM at a resolution 
of 3.5Å (Jegerschöld et al. 2008). The structure suggests that the enzyme functions as a 
homotrimer (figure 5), with each monomer composed of four transmembrane helices. 
Mutation of Arg67, Arg110 or Tyr117 to Ala lead to loss of enzyme activity, implying 
that these residues are crucial for enzyme activity (figure 6). Tyr117, Arg126, Tyr130 
and Gln134 bind to glutathione. Other important residues include Glu66 and His72, the 
mutation of which results in reduction of enzyme activity by 50% and 70%, 
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respectively, compared to the wild type protein (Jegerschöld et al. 2008). The crystal 
structure of human mPGES-1 has elaborated three well-defined catalytic sites on the 
interface of the monomers and a small extra cytosolic domain inserted between helices I 
and II, which does not exist in members of the MAPGE family (Sjogren et al. 2013). 
Ser127 was suggested to play a critical role the catalytic mechanism of PGES-1 because 
the hydroxyl group of Ser127 assists the formation of glutathione thiolate and stabilizes 
it (Sjogren et al. 2013).  
 
Figure 5. Human PGES-1 (PDB ID: 3DWW) forms a homotrimer. Each monomer is composed of 
four helices. Yellow, green and blue represent three monomers.  
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Figure 6. Catalytic and other important residues in human PGES-1 (PDB ID: 4AL1). Tyr117, 
Arg126, Tyr130 and Gln134 bind to glutathione analog 1-(4-phenylphenyl)-2-(S-glutathionyl)-ethanone 
(biphenyl-GSH). Tyr117, Arg126, Tyr130 and Gln134 are represented as blue sticks. Other functionally 
important residues including Glu66, Arg67, His72, Arg110 and Ser127 are shown as purple sticks. 
Glutathione analog 1-(4-phenylphenyl)-2-(S-glutathionyl)-ethanone (biphenyl-GSH) is shown as red 
sticks. PGES-1 monomer is rendered in green cartoon. 
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Yamamoto et al. identified, purified and crystalized a glutathione transferase that 
exhibits prostaglandin E synthase activity from silkworm Bombyx mori (K. Yamamoto 
et al. 2013). The isolated B. mori glutathione transferase (GSTS1) shares 44.5% 
sequence identity with D. melanogaster GSTS-1 (CG8938). The amino acid sequence 
alignment indicates B. mori GSTS1, D. melanogaster GSTS-1 and rat PGDS share high 
sequence identity and similarity. 
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Prostaglandin E Synthase-2 (PGES-2/mPGES-2) 
PGES-2, also known as mPGES-2, is synthesized as a Golgi membrane-
associated protein, but it functions as a cytosolic enzyme after its N-terminal 
hydrophobic domain is proteolytically removed (Makoto Murakami et al. 2003). PGES-
2 consists of 378-385 amino acids, and is structurally distinct from PGES-1 (Jegerschöld 
et al. 2008; Yamada et al. 2005). It differs from PGES-1 because its activity is not 
glutathione dependent (Tanikawa et al. 2002).  
Initial studies based on the crystal structure of PGES-2 suggested that it forms a 
dimer and is attached to the membrane by its N-terminal region (figure 7)(Yamada et al. 
2005). However, Murakami et al. discovered that the formation of a mature PGES-2 
required proteolytic removal of its hydrophobic N-terminus, which leads to the 
formation of a cytosolic protein (Makoto Murakami et al. 2003). Therefore, PGES-2 
functions as a cytosolic protein, since its membrane-bound N-terminal region is 
truncated in the mature form. Adjacent to the hydrophobic domain, PGES-2 has a 
glutaredoxin/thioredoxin domain, which contains the thioredoxin consensus sequence 
Cys110-X-X-Cys113. Cys110 is the catalytic site of PGES-2, mutation of which results 
in loss of enzyme activity (Kikuko Watanabe et al. 2003). The substrate PGH2 fits into 
the V-shaped catalytic pocket, and its endoperoxide moiety makes contacts with the SH 
functional group of Cys110 (figure 8). SH-reducing reagents, including dithiothreitol, 
GSH and β-mercaptoethanol are required for enzymatic activity in vitro (Kikuko 
Watanabe et al. 2003). 
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Figure 7. Macaca fascicularis PGES-2 (PDB ID: 1Z9H) functions as dimers. Two subunits (yellow 
and green, purple and pink) form a dimer. There is also weak dimer-dimer interaction between the two 
dimers (Yamada et al. 2005).  
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Figure 8. Important residues in Macaca fascicularis PGES-2 (PDB ID: 1Z9H). Cys110-X-X-Cys113 
thioredoxin consensus sequence is shown as purple sticks. Indomethacin, the analog of substrate PGH2, is 
shown as red sticks. Subunit of Macaca fascicularis PGES-2 is rendered in green cartoon. 
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Unlike PGES-1, which has very low basal expression level in normal tissues, 
basal transcriptional expression level of PGES-2 is much higher in a variety of tissues, 
such as brain, heart, skeletal muscle, kidney and liver, and the expression level of PGES-
2 is tissue-dependent (Tanikawa et al. 2002). In most tissues, the expression level 
PGES-2 is not elevated dramatically by inflammation. However, transcriptional 
expression level of PGES-2 is elevated significantly in colorectal cancer and bone 
marrow stromal cells, where PGES-1 shows increased expression level as well (Makoto 
Murakami et al. 2003; Ueno et al. 2005). 
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Prostaglandin E Synthase-3 (PGES-3/cPGES) 
In 2000, Tanioka et al. isolated, purified and identified cytosolic glutathione 
(GSH)-dependent PGES-3 from LPS-treated rat brain, and discovered that it is identical 
to the previously identified p23, which is a ubiquitous, highly conserved protein 
originally implicated to function as a co-chaperone for heat shock protein hsp90 (T 
Tanioka et al. 2000; Weaver et al. 2000). Constitutively expressed cytosolic PGES-3, 
also known as cPGES, has been observed in various types of cells and is functionally 
linked to the constitutively expressed COX-1 (T Tanioka et al. 2000).  
PGES-3 and COX-1’s functional coupling suggests that they have similar 
functions, which include gastrointestinal movement, reproduction and some neural 
functions. Research suggests that PGES-3 is essential for prenatal survival embryonic 
growth, and not as much for PGE2 synthesis. PGES-3 deficient mice have various 
defective growth conditions including poor lung maturation and hindered skin 
development (Grad et al. 2006; Nakatani et al. 2007; Lovgren, Kovarova, and Koller 
2007). Recent studies by Simpson et al. and Mattila et al. show that high level of cPGES 
results in elevated level of lymph node metastases and drug resistance, which in turn 
promotes tumor growth in breast cancer (Simpson et al. 2010; Mattila et al. 2009). Their 
study also shows overexpression of cPGES in human gliomas, suggesting that cPGES 
may play a role in inflammation. Similar to PGES-1, PGES-3 is GSH-dependent, and it 
requires GSH as its co-factor to reach optimal activity (T Tanioka et al. 2000).  
PGES-3 belongs to the glutathione S-transferase (GSTs; EC 2.5.1.18) family, a 
large protein family composed of multifunction enzymes including structurally unrelated 
cytosolic enzymes and microsomal enzymes that are traditionally considered to be 
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involved in metabolic detoxication of electrophiles by glutathione conjugation (Johnson 
et al. 1993; Mannervik and Danielson 1988; Vos and Van Bladeren 1990; Hayes and 
Strange 2000). The structure of human PGES-3 was solved in 2000 by Weaver et al. 
(Weaver et al. 2000). Tyr9 in PGES is conserved in several other GSTs, and mutation of 
Tyr9 abolishes GST activity of cPGES (T Tanioka et al. 2000). Tanioka et al. found that 
Tyr9, which is known to be essential for enzymatic activity of PGES-3 as a glutathione 
S-transferase, is crucial for PGES synthesis activity as well (Johnson et al. 1993; T 
Tanioka et al. 2000). PGES-3 functions as a homodimer (figure 9).  
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Figure 9. Human PGES-3 (PDB ID: 1EJF) forms a homodimer. Tyr9, which is required for the 
glutathione S-transferase activity of PGES-3, is essential for its PGES enzymatic activity. 
The two subunits were shown in green and yellow cartoons. Tyr9 is shown as red sticks. 
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Project Rationale 
The value of the Drosophila as a model organism is well established, and 
multiple resources in terms of genetic tools, databases, and mutants are currently 
available to address important biological questions (Kalajdzic et al. 2012; Chintapalli, 
Wang, and Dow 2007). Overall, flies share extensive genetic similarities with 
vertebrates. Furthermore, it is well‐documented that the fundamental regulatory 
signaling mechanisms that control cellular physiology in flies and humans are 
essentially conserved (Medzhitov and Janeway Jr 2000). Given the importance of 
eicosanoids in mammalian and insect immune systems, this study was designed to allow 
us to identify the enzymes that mediate eicosanoid biosynthesis in Drosophila 
computationally. After a preliminary scan for putative homologues for all enzymes in 
the COX pathway, a systematic, comprehensive, and detailed computational 
investigation was undertaken for two enzymes, COX and Prostaglandin E synthase in an 
endeavor to model and characterize the possible candidates and identify those that 
possess all the requisite sequence and structural motifs to qualify as valid COX(s) / PGE 
synthase proteins and make suitable candidates for further experimental investigations. 
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Chapter 2 Methods 
Identification of homologues of COX, PGE Synthase and 
other enzymes of COX pathway in D. melanogaster  
Putative COX homologous proteins, putative PGES homologous proteins, and 
other putative homologous proteins in COX pathway in D. melanogaster were identified 
using BLASTp, PSI-BLAST (position-specific iterated BLAST)(Altschul et al. 1990) 
and HMMER (Finn, Clements, and Eddy 2011). Then the amino acid sequences of the 
proteins were retrieved from NCBI protein sequence database in fasta format. BLASTp 
and PSI-BLAST were run against the D. melanogaster genome database (version 
FB2013_02, released March 8th, 2013) using human enzymes in COX pathway as input 
sequences. For BLASTp, E-value cutoff was set to 1E-5, and queries with coverage 
more than 45% were taken as candidates. Five iterations of PSI-BLAST were used, 
initial expect threshold was set to 0.01. HMMER implements profile hidden Markov 
models (profile HMMs) to searching sequence database for homologous proteins. 
Comprehensive results identified by BLASTp, HMMER and PSI-BLAST were kept as 
candidates. The individual accession numbers, chromosomal location, and residue 
lengths of the candidates were verified by scanning various databases manually to 
eliminate any ambiguities and annotation errors.  
Domain architecture analysis 
The retrieved candidate sequences were verified for existence of their 
characteristic catalytic domains: COX protein sequences for the animal peroxidase 
domain, PGES-1 protein sequences for the MAPGE domain, PGES-2 protein sequences 
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for glutathione S-transferase N-terminal domain (GST_N) and glutathione S-transferase 
C-terminal domain (GST_C), and PGES-3 protein sequence for p23/CS (CHORD-
containing proteins and SGT1) domain respectively. Details of their domain architecture 
were verified using four different domain architecture analysis software: CDD 
(Marchler-Bauer et al. 2009), Prosite (de Castro et al. 2006; Sigrist et al. 2010; Sigrist et 
al. 2005), SMART (Letunic, Doerks, and Bork 2009; Schultz et al. 1998) and Pfam 
(Finn et al. 2010). CD-search is NCBI’s online searching tool against CDD (Conserved 
Domains and Protein Classification), a protein annotation resource based on PSSMs 
(pre-calculated position-specific scoring metrices) and PRS-BLAST (reverse position-
specific BLAST), a variant of PSI-BLAST (Marchler-Bauer et al. 2009). Pfam is a 
protein family database, and each family is represented by multiple sequence alignments 
and hidden Markov models (HMMS) (Finn et al. 2010). PROSITE is the database of 
protein domains, families and function site of SIB (Swiss Institute of Bioinformatics) as 
part of ExPaSy (Expert Protein Analysis System, the portal of SIB). PROSITE includes 
documentations describing protein domains, families and functional residues and 
associated patterns and motifs (de Castro et al. 2006). The domain boundaries were 
verified using secondary structure prediction programs as described below. 
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Secondary structure prediction  
The boundaries of the domains in the protein sequences analyzed were 
ascertained based on the consensus output from a number of secondary structure 
prediction programs: Jpred (Cole, Barber, and Barton 2008), porter (Pollastri and 
McLysaght 2005), PredictProtein (Rost and Liu 2003), psipred (D. T. Jones 1999), 
sopma (Geourjon and Deléage 1995) and sspro (J. Cheng et al. 2005). The consensus 
secondary structure prediction for each sequence was also used to verify the accuracy of 
template–target alignments used in modeling their three dimensional structure.  
Multiple sequence alignment and characterization of target 
sequence 
In order to evaluate the key residues responsible for biochemical catalytic 
function of the protein, amino acid sequences of putative D. melanogaster were 
compared with mammalian sequences for the enzymes. Different programs such as T-
Coffee (Notredame, Higgins, and Heringa 2000), CLUSTAL (Thompson, Higgins, and 
Gibson 1994), and Muscle (Edgar 2004) were used to generate optimal alignments, and 
ESPript was used to generate visualization of the alignments (Gouet et al. 1999).  
Transmembrane helices in the target sequence were predicted using TMpred 
(Hofmann and Stoffel 1993), TMHMM (Möller, Croning, and Apweiler 2001) and 
SOSUI (Hirokawa, Boon-Chieng, and Mitaku 1998), and the consensus results were 
used. To predict the presence and location of a signal peptide in D. melanogaster 
putative COXs, four programs PrediSi (Hiller et al. 2003), SignalP4 (Petersen et al. 
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2011), SIGPred (Bradford 2001) and Signal-3L (H.-B. Shen and Chou 2007) were used. 
The consensus results were used. 
Phylogenetic tree 
To reconstruct the evolutionary relationship of COX proteins from different 
phyla, the PhyML (Guindon and Gascuel 2003) package from Phylogeny.fr (Dereeper et 
al. 2008) was used as follows: the multiple sequence alignment was built using Muscle 
(Edgar 2004) in default run mode and maximum 16 iterations; Gblock (Castresana 2000) 
was used for curation with the following parameters: smaller final blocks not allowed, 
gap position within the final blocks not allowed, less strict flanking positions not 
allowed, and many contiguous non-conserved positions allowed; Phylogentic tree was 
built based on maximum likelihood using the PhyML (Guindon and Gascuel 2003) 
package using the following parameters: 100 bootstraps, default substitution model with 
4 substitution rate categories, automatic estimation of substitution parameter, automatic 
estimation of proportion of invariable sites, and removal of gaps in sequence alignment 
prior to building phylogenetic tree. The tree was visualized using FigTree v1.3 (Morris 
et al. 1998). 
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Structural modeling, model refinement and evaluation 
Molecular modeling 
A combination of comparative modeling techniques and ab initio approaches 
were used to generate high-quality three-dimensional models for the catalytic domains 
of D. melanogaster COX homologues Pxt, Pxd and CG4009, PGES-1 homologues 
Mgsl, CG33177 and CG33178, PGES-2 homologue Su(2)P and PGES-3 homologue 
CG16817 as outlined in the flowchart in figure 10.  
 
Figure 10. Flowchart of molecular modeling 
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Structural modeling of COX homologues Pxt, Pxd and CG4009 
Multiple models for the catalytic domains of D. melanogaster Pxt, Pxd, and 
CG4009 proteins were built using various modeling programs. Human myeloperoxidase 
(PDB ID: 1MHL) was identified as the top ranked structural template by the fold-
recognition software FUGUE (Shi, Blundell, and Mizuguchi 2001), while HHpred 
(Söding, Biegert, and Lupas 2005) identified Bos taurus lactoperoxidase (PDB ID: 
3Q9K) as a high confidence structural template for the conserved catalytic domains of 
D. melanogaster COX candidates. The preliminary sequence alignments between the 
structural templates 1MHL and 3Q9K and the D. melanogaster proteins obtained from 
FUGUE (Shi, Blundell, and Mizuguchi 2001) and HHpred (Söding, Biegert, and Lupas 
2005), respectively, were optimized and used to generate the three dimensional models 
using the program modeller 9v9 (Eswar et al. 2006).  
Structural modeling of PGES-1 homologues Mgsl, CG33177 and CG33178  
Using a similar approach as detailed above, the structure of the Homo sapiens 
microsomal prostaglandin E synthase-1 (PDB code 3DWW) identified by HHpred as a 
high confidence structural template was used for modeling for the full length sequence 
of D. melanogaster PGES-1 candidates, Mgsl, CG33177 and CG33178.  
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Structural modeling of PGES-2 homologue Su(2)P 
 HHpred (Söding, Biegert, and Lupas 2005) identified the structure of Macaca 
fascicularis microsomal prostaglandin E synthase-2 (PDB code 1Z9H) as the high 
confidence structural template for the conserved catalytic domain (residues 110-399) of 
D. melanogaster PGES-2 candidate Su(2)P. The sequence alignment between the 
structural template 1Z9H and D. melanogaster protein Su(2)P obtained from HHpred 
(Söding, Biegert, and Lupas 2005), was used to generate the three dimensional models 
using the program modeller 9v9. 
Structural modeling of PGES-3 homologue CG16817 
 Homo sapiens co-chaperone P23 (PDB code 1EJF) was selected as the structural 
template for the conserved CS domain (residues 1-96) of D. melanogaster PGES-3 
candidate CG16817, and used for creating its molecular models based on the HHPred 
generated alignment. The generated molecular models were refined in the same manner 
as the models for the other homologues. 
Model refinement and evaluation 
After models were constructed, loop refinement, side-chain packing and energy 
minimization were carried out by Scwrl4 (Canutescu, Shelenkov, and Dunbrack 2003).  
Besides the structural models of the catalytic domain, full-length models were also built 
for structural analysis of regions beyond the catalytic domains. Full-length models were 
constructed using I-TASSER (iterative threading assembly refinement) (Zhang 2008). I-
TASSER is an automated integrated protein structure calculation server that utilizes the 
sequence-to-structure-to-function algorithm to calculate the three dimensional structure 
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of the query sequence. It first computes the secondary structure of the query sequence 
using multiple threading alignments and iterative structural assembly simulation, and 
then matches the 3D model with known protein structures in BioLip protein function 
database (Yang, Roy, and Zhang 2013). The best representative model was picked based 
on the z-score and knowledge-based energy score calculated using verify3D (Lüthy, 
Bowie, and Eisenberg 1992) and Prosa (Wiederstein and Sippl 2007). Structural 
alignment between catalytic domain of putative Drosophila melanogaster protein and 
sheep COX-1 (PDB ID 1CQE), human PGES-1 (PDB ID 3DWW), monkey PGES-2 
(PDB ID 1Z9H), or human PGES-3 (PDB ID 1EJF) was calculated using CE protein 
server (Shindyalov and Bourne 1998). Finally, visualization of protein models was 
performed using Pymol (DeLano 2002).  
Docking analysis 
To understand the possible interactions between the ligands as co-factors and D. 
melanogaster COX candidates at the molecular level, flexible docking was performed 
using Autodock 4.0 (Morris et al. 1998). The structures of heme (PDB ligand ID HEM), 
linoleic acid (PDB ligand ID EIC) and arachidonic acid (PDB ligand ID ACD) ligands 
were obtain from Ligand Expo (Berman, Henrick, and Nakamura 2003) in PDB format. 
Polar hydrogen atoms were added to the protein, and then a total Kollman charge was 
assigned to the protein, and all non-polar hydrogen atoms were merged. For all the 
ligands, polar hydrogen atoms were added, and Gasteiger charge was calculated and 
assigned to the ligands, and then all the non-polar hydrogen atoms were merged, and 
torsion-tree was detected automatically using Autodock. After both receptor and ligand 
were processed and imported to AutoDock, grids were generated using AutoGrid. The 
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location and size of grids were manually adjusted, based on our prediction of the 
location of the ligand. Lamarckian Genetic Algorithm with the default parameter 
settings were performed for each docking, and the docked results were evaluated based 
on energy. The docked complex of the ligand and the protein with the lowest energy was 
further analyzed and visualized using Pymol (DeLano 2002). 
COX activity assay 
Fly stock 
All fly stocks were maintained on standard cornmeal-agar-yeast medium at 25 
°C. y w flies (wild-type) were used as the control in all the experiments. pxtf01000 strain 
was obtained from the Harvard Exelixis collection. pxtf01000 contains a Piggybac 
insertion within the 5’ UTR of the gene, and the insertion is located 38 bp upstream of 
the start codon (Thibault et al. 2004). pxtf01000 strain has significantly lower 
transcriptional expression level of pxt in the whole fly, confirmed by Tootle et al. 
(Tootle and Spradling 2008). 
Fly sample preparation  
For each experimental group and control group, 40-80 adult flies were collected 
in a centrifuge tube, and the centrifuge tube was placed in a -20°C freezer for at least 45 
minutes. Quiescent flies were weighed and transferred into a microtube, and mixed with 
6.8 ml cold buffer (0.1 M Tris-HCl, pH 8.0 containing 1 mM EDTA) per mg of flies. 
Flies were then homogenized on ice. Homogenized flies were then centrifuged at 10,000 
X g for 15 minutes at 4°C. After centrifuging, the supernatant was moved to new 
microtubes, stored on ice and used for the assay. 
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COX activity analysis 
Cyclooxygenase is a bifunctional enzyme and has cyclooxygenase and 
peroxidase activities. The cyclooxygnase activity converts arachidonic acid into PGG2, 
while the peroxidase activity converts PGG2 to PGH2, which is the precursor of 
prostaglandins, thromboxanes and prostacyclins. 
Cayman's COX activity assay kit (Cayman Chemical Item Number 760151) 
measures the peroxidase activity of COX proteins. The peroxidase activity of COX 
catalyzes the reaction that converts tetramethyl-p-phenylenediamine (TMPD) to N, N, 
N’, N’- tetramethyl-p-phenylenediamine (TMPD). The kit measures the peroxidase 
activity of COX by monitoring the appearance of N, N, N’, N’- tetramethyl-p-
phenylenediamine (TMPD) at 590 nm. (Van der Ouderaa et al. 1977; Kulmacz and 
Lands 1983) 
The protocol in the Cayman's COX activity assay kit was used in this assay. 
Inactive samples were prepared as following: 50 µL of supernatant obtained after 
centrifuging the fly sample preparation was transferred to a 1.5 mL microtube, then 
placed in boiling water for five minute. Background wells contained 150 µL assay 
buffer, 10 µL heme solution and 10 µL inactive sample per well. Sample wells contained 
150 µL assay buffer, 10 µL heme, 10 µL untreated supernatant sample per well. After 
adding reagents to background wells and samples wells, the 96-well plate was carefully 
shaken until the contents were thoroughly mixed, and then the plate was incubated for 
five minutes at 25°C. After the five-minute incubation, 20 µL of colorimetric substrate 
was added to every well. The reaction was initiated by adding 20 µL of arachidonic acid 
solution to each well. The plate was again carefully shaken and incubated for five 
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minutes at 25°C. Wells of the plate were read using a plate reader at the absorbance 
590nm. 
Total COX activity was calculated as following: 
ΔA590 = A590 [sample] - A590 [background] 
 
Three repetitions of COX activity assays were performed. The COX activity of 
each repetition was normalized by setting the total COX activity of y w female as 100%. 
A paired two-tail t-test was performed using Excel for each two of the three repetitions 
to determine whether the experimental results from two repetitions were significantly 
different. 
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Chapter 3 Mapping enzymes of the cyclooxygenase 
pathway in Drosophila melanogaster 
 The mammalian COX pathway is well documented and extensively investigated 
(Table 2). The mammalian COX pathway includes multiple proteins that catalyze nine 
well characterized enzymatic reactions (William L Smith, Urade, and Jakobsson 2011). 
Table 2 summarizes the nine-enzymatic reactions catalyzed by various enzymes with 
distinct structural folds and catalytic mechanisms. 
Table 2. List of all the enzymes in COX pathway 
Reaction EC Enzyme full names NCBI locus (human) Reference 
AA → PGH2 EC 1.14.99.1 
Cyclooxygenase-1 (COX-1) NP_000953.2 (Yokoyama and Tanabe 1989) 
Cyclooxygenase-2 (COX-2) NP_000954.1 (D. A. Jones et al. 1993) 
PGH2 → 
TxA2 
EC 5.3.99.5 
Cytochrome P450, family 5, 
subfamily A (CYP5A); 
thromboxane-A synthase 
(TBXAS1) 
NP_001052 
(Yokoyama et al. 
1991) 
PGH2 → 
PGE2 
EC 5.3.99.3 Prostaglandin-E synthase 1 (PGES-1/mPGES-1) NP_004869 
(Jakobsson et al. 
1999) 
EC 5.3.99.3 Prostaglandin-E synthase 2 (PGES-2/mPGES-2) NP_079348 
(Tanikawa et al. 
2002) 
EC 5.3.99.3 Prostaglandin-E synthase 3 (PGES-3/cPGES) NP_006592.3 
(T Tanioka et al. 
2000) 
PGE2 → 
PGF2α 
EC 1.1.1.184; 
EC 1.1.1.189; 
EC 1.1.1.197 
Prostaglandin-E2 9-reductase; 
carbonyl reductase (NADPH) 
(CBR1) 
NP_001748 
(Wermuth et al. 
1988) 
EC 1.1.1.184 Carbonyl reductase-2 (CBR2) NA  
EC 1.1.1.184; 
EC 1.1.1.189; 
EC 1.1.1.197 
Carbonyl reductase-3 (CBR3, 
similar to CBR1) NP_001227 
(Koji Watanabe et al. 
1998) 
EC 1.1.1.184 Carbonyl reductase-4 (CBR4) NP_116172.2 
(S. Endo et al. 2008) 
PGH2 → 
PGD2 
EC 2.5.1.18; 
EC 5.3.99.2 
Hematopoietic prostaglandin D 
synthase (H-PGDS) NP_055300 
(Kanaoka et al. 2000) 
EC 5.3.99.2 Lipocalin-type prostaglandin D synthase (L-PGDS) NP_000945 
(White et al. 1992) 
PGH2 
→PGF2α 
EC 1.1.1.188 Prostaglandin F synthase (PGFS) NP_001182665.1 
(Moriuchi et al. 2008) 
PGE2 → 
PGF2α 
EC 1.1.1.184; 
EC 1.1.1.189; 
EC 1.1.1.197 
PGE 9-ketoreductase  = CBR1  NP_001748 
(Wermuth 1981) 
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PGD2 → 9α, 
11β-PGF2α 
EC 1.1.1.213 
EC 1.1.1.112 
EC 1.1.1.188 
EC 1.1.1.239 
EC 1.1.1.64 
EC 1.3.1.20 
Aldo-keto reductase family 1 
member C3; PGD 11-
ketoreductase 
NP_003730.4 
(Suzuki-Yamamoto et 
al. 1999) 
PGH2 → 
PGI2 
EC 5.3.99.4 
Cytochrome P450, family 8, 
subfamily A (CYP8A); 
Prostacyclin synthase (PGIS) 
NP_000952 
(Miyata et al. 1994) 
 
 We have been able to identify a majority of the homologues in D. melanogaster 
based on sequence similarity with known enzymes from vertebrates and/or invertebrates 
(overall 14-39% sequence identity) in the COX pathway (figure 11), indicating that the 
enzyme structures show sufficiently high sequence conservation. In some instances (e.g., 
COX), more than one homologue has been identified. To confirm that, in principle, a 
functional enzyme was identified, an initial investigation of each of the putative enzyme 
sequences was performed for (1) conserved catalytic domains, and (2) catalytic 
signatures (based on sequence alignments as well as structural superposition where the 
catalytic domain was successfully modeled).  Our preliminary scan has identified 
putative homologues for COXs, PGES, carbonyl reductase (CBR), hematopoietic 
prostaglandin D synthase (H-PGDS), PGD 11-ketoreducatse, prostacyclin synthase and 
thromboxane-A synthase (figure 11).  
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 Figure 11. Putative D. melanogaster enzymes of the COX pathway 
 
 Two of these enzymes, COX and PGE synthase, were subsequently subjected to 
detailed investigation described in the following chapters (chapter 4 and chapter 5). The 
preliminary analysis upon which the assignment of putative homologs for the other 
enzymes is based on is described below. 
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Theoretical assignment of CG11210 as carbonyl reductase 
(CBR) 
Carbonyl reductases (CBRs, EC 1.1.1.184; EC 1.1.1.189; EC 1.1.1.197) are 
NADPH-dependent oxidoreductases that catalyze the production of PGF2α using PGE2 
as the substrate. CBRs belong to short chain dehydrogenases/reductases (SDR) family 
(Forrest and Gonzalez 2000; Nelson et al. 1993). There are three CBRs in Homo 
sapiens, CBR-1, CBR-3 and CBR-4, and their sequences are highly similar (figure 12). 
Our initial analysis has identified D. melanogaster protein CG11210 (accession 
NP_725952.1) as a CBR homologue. CG11210 shares 20% sequence identity and 33% 
sequence similarity with hCBR-1, and it contains the classic conserved sequences of all 
CBRs (figure 12), which include the cofactor binding region Rossmann fold 
GlyXXXGlyXGly at residues 12-18 and the conserved catalytic sequence TyrXXXLys 
at residues 194-198 (Forrest and Gonzalez 2000; Oppermann et al. 1998).  
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Figure 12. Alignment of human CBRs and D. melanogaster CBR. Identical/similar residues are boxed 
in red/white. Purple boxes show conserved sequences Rossmann fold GlyXXXGlyXGly (residues 12-18) 
and TyrXXXLys (residues 194-198). Conserved Tyr194 is marked with a blue arrow.  
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Theoretical assignment of DmGSTS1-1 as hematopoietic 
prostaglandin D synthase 
PGDS catalyzes the synthesis of PGD2. There are two different types of PGDSs 
in mammals: hematopoietic prostaglandin D synthase (H-PGDS) and lipocalin-type 
prostaglandin D synthase (L-PGDS), also called glutathione-independent PGD synthase 
(table 3). The two types of PGDS differ in tissue location, cofactor and activators, and 
they can be distinguished by their sequences through their differing catalytic signatures 
(Table 3; Urade et al. 1993; Gerena et al. 1998; Tokugawa et al. 1998; Eguchi et al. 
1997; Lewis et al. 1982). 
 
Table 3. Comparison of H-PGDS and L-PGDS 
 Hematopoietic 
prostaglandin D synthase 
(H-PGDS) 
Lipocalin-type 
prostaglandin D2 synthase 
(L-PGDS)/Prostaglandin-H2 
D-isomerase 
NCBI accession No./human NP_055300.1 NP_000945.3 
Amino acid 199aa 190aa 
Molecular weight 23kDa 21kDa 
Chromosomal location 4q22.3 9q34.2-q34.3 
Subunit Dimer Monomer  
Tissue locations Mast cells, Th2 cells and 
microglia 
Brain, male genital organs 
and heart 
Activator Mg2+, Ca2+  
Co-factor GSH Sulfhydryl compounds 
PDB 4EDY, 4EE0, 4EC0, 4EDZ, 
3VI5, 3VI7, 2KXO, 3EE2, 
4IMN, 4IMO, 3O19, 3O22, 
3O2Y, 2WWP 
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2VCQ, 2VCW, 2VCX, 
2VCZ, 2VD0, 2VD1, 
1V40, 1IYH, 1IYI 
EC EC 2.5.1.18 
EC 5.3.99.2  
EC 5.3.99.2 
 
 Our initial analysis suggests that D. melanogaster possesses only one of the two 
types of enzymes. We identified DmGSTS1-1 (CG8938, glutathione S transferase S1), a 
well studied and characterized protein (Agianian et al. 2003; Singh et al. 2001; Agianian 
et al. 2001) as the putative H-PGDS. Structure-based sequence alignment of human H-
PGDS and DmGSTS1-1 shows that they share 35% sequence identity and 58% sequence 
similarity. DmGSTS1-1 has the majority of key functional residues of human H-PGDS 
(figure 13). Key functional residues of hH-PGDS include (1) Tyr8 and Arg14, which are 
involved in stabilization of the thiol group of GSH; (2) Trp104, which is required to 
sustain the catalytic cleft in the active form of the enzyme (Pinzar et al. 2000); (3) 
Asp93, Asp96 and Asp97, which are the metal activation sites(Inoue et al. 2003). 
DmGSTS1-1 is missing Arg14, Trp104 and Asp96. In place of Arg14, Trp104 and 
Asp96, DmGSTS1-1 possesses Leu60, Ser152 and Asn142, respectively (figure 13). 
Despite the differences in the above residues, the residues of DmGSTS1-1 possess 
similar position as the human counterparts (figure 14). Structural alignment shows that 
the structural folds of DmGSTS1-1 and human H-PGDS are highly similar with RMSD 
2.24Å (figure 14). Saisawang et al. discovered that DmGSTS1-1 is capable of utilizing 
4-HNE (4-hydroxynonenal), adrenchrome and PEITC (phenethyl isothiocyanate) as 
substrates in vitro (Saisawang, Wongsantichon, and Ketterman 2012).  
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Figure 13. Sequence alignment of human H-PGDS (hH-PGDS) and DmGSTS-1. Top secondary 
structure was extracted from hH-PGDS (PDB ID 4EC0) and bottom secondary structure was extracted 
from DmGSTS-1 (PDB ID 1M0U). Key functional residues, Tyr8, Arg14, Trp104, Asp93, Asp96 and 
Asp97, are marked with blue arrows.  
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Figure 14. Structural alignment of hH-PGDS and DmGSTS1-1, showing the key functional residues. 
Protein structures are rendered in cartoon. hH-PGDS (PDB ID 4EC0) is shown in yellow, and DmGSTS1-
1 (PDB ID 1M0U) is shown in green. Key residues - Tyr4, Arg13, Trp104, Asp93, Asp96 and Asp97 of 
hH-PGDS are shown as orange sticks. Key residues – Tyr54, Asp139 and Asp143 of DmGSTS1-1 are 
shown as purple sticks. Residues of DmGSTS-1, Leu60, Ser152 and Asn142 that are different from the 
human counterparts are shown as blue sticks.  
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Theoretical assignment of CG6084 et al. as PGD 11-
ketoreducatse 
PGD 11-ketoreductase, also known as aldo-keto reductase family 1 member C3 
(AKR1C3) is one of the three enzymes that catalyze the synthesis of PGF2α (table 4) 
(Kikuko Watanabe 2002). PGD 11-ketoreductase reduces the 11-keto group of PGD2 
and produces 9α, 11β-PGF2α, which is a PGF2α stereoisomer (Chen, Watanabe, and 
Hayaishi 1992). 
Table 4. Comparison of all the enzymes that catalyze the reactions that produce PGF2α 
 Prostaglandin F 
synthase 
PGE 9-ketoreductase = 
Carbonyl reductase 1 
PGD 11-
ketoreductase 
EC 1.1.1.188 1.1.1.189 1.1.1.188 
Substrate PGH2 PGEs PGD2 
Product PGF22α PGF2α 9α, 11β-PGF2α 
 
Our preliminary research identified multiple D. melanogaster proteins that could 
be PGD 11-ketoreductases. The proteins include CG4083, CG4084, CG10638, 
CG12766, CG10863, CG9436, CG2767, and CG40064. Sequence identity between D. 
melanogaster proteins and human PGD 11-ketoreductase ranges from 29% to 47%; 
Sequence similarity between D. melanogaster proteins and human PGD 11-
ketoreductase ranges from 44% to 66%. All the D. melanogaster proteins contain the 
catalytic residues Tyr55, Lys84 and His117 (figure 15) (Liedtke et al. 2013). 
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Figure 15. Alignment of human PGD 11-ketoreductase of D. melanogaster proteins CG4083, 
CG4084, CG10638, CG12766, CG10863, CG9436, CG2767, and CG40064. Secondary structure of 
human PGD 11-ketoreductase is obtained from human PGD 11-ketoreductase (PDB ID 4DBW). 
Identical/similar residues are boxed in red/white. Catalytic residues Tyr55, Lys84 and His117 are marked 
with blue arrows. 
  
	  58	  
Theoretical assignment of CYP18a1 et al. as prostacyclin 
synthase (prostaglandin I synthase, PGIS) 
 PGIS catalyzes the reaction that converts PGH2 into PGI2. Our initial analysis 
identified nine D. melanogaster proteins, including CYP18a1, CYP28a5, CYP28d1, 
CYP28d2, CYP4aa1, CYP4g15, CYP6a13, CYP6d5 and CYP8h1, that share sequence 
similarity with human PGIS (hPGIS) and possess the key catalytic signature of a PGIS 
(figure 16). All the D. melanogaster CYP proteins have the key residues required for the 
catalytic reaction, which include Cys441 (heme iron binding), and Glu347 and Arg350, 
which are required for the catalytic activity (Hatae et al. 1996, 441). Sequence 
identity/similarity between hPGIS and D. melanogaster proteins is 12-15%/29-32%.  
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Figure 16. Alignment of hPGIS and D. melanogaster proteins CYP18a1, CYP28a5, CYP28d1, 
CYP28d2, CYP4aa1, CYP4g15, CYP6a13, CYP6d5 and CYP8h1. Secondary structure is obtained 
from hPGIS (PDB ID 2IAG). Identical/similar residues are boxed in red/white. Catalytically important 
residues Cys441, Glu347 and Arg350 are marked with blue arrows. 
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Theoretical assignment of CYP6a18 et al. as thromboxane-A 
synthase  
 Thromboxane-A synthase (TBXAS) catalyzes the reaction that converts PGH2 
into TxA2. Our initial analysis identified many D. melanogaster CYP proteins that share 
sequence similarity with human thromboxane-A synthase (hTBXAS), which include 
CYP6a18, CYP6a19, CYP6a8, CYP6t1, CYP6w1 and CYP9c1 (figure 17). Sequence 
similarity and identity between hTBXAS and D. melanogaster proteins ranges from 24-
26% and 43-48%, respectively. Very little is known about the catalytic mechanism of 
this enzyme (Ullrich 2003). The structure of thromboxane-A synthase has not been 
solved, and very little is known about the enzyme and its mechanism (William L Smith, 
Urade, and Jakobsson 2011).  
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Figure 17. Sequence alignment of hTBXAS and D. melanogaster proteins CYP6a18, CYP6a19, 
CYP6a8, CYP6t1, CYP6w1 and CYP9c1. Identical/similar residues are boxed in red/white.  
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Chapter 4 Identification and Characterization of 
Putative Cyclooxygenase Enzymes in Drosophila 
melanogaster 
Identification, chromosomal localization, and domain 
architectures of ten candidate COXs in D. melanogaster 
We have identified ten candidate COX proteins from the D. melanogaster 
genome database (Release 5.30, May 16th, 2011) using a combination of iterative 
BLAST and HMMER searches based on sequence similarity with the hCOX-1 protein: 
CG3131 (dual oxidase (Duox)), CG3477 (peroxidase (Pxd)), CG4009, CG5873, 
CG6969 (Cardinal), CG7660 (peroxinectin-like (Pxt)), CG8913 (immune regulated 
catalase (Irc)), CG10211, CG12002 (peroxidasin (Pxn)) and CG42331 (Table 5). 
Among these genes, pxd, pxn, and CG6969 are predicted to encode two protein isoforms 
due to alternative splicing. Seven of the ten candidate COX encoding genes are located 
on the right arm on chromosome 3, CG3131 and CG10211 are located on left arm of 
chromosome 2, and CG12002 is located on the left arm of chromosome 3 (Figure 18).  
 
	  64	  
Table 5. Length, CG number, chromosomal location and evidence level of the ten proteins in D. 
melanogaster 
 
 
  
BLAST hits GI  Length CG number Chromosoma
l location 
Evidence level 
CG4009 24647576 649aa CG4009 3R Transcript 
CG5873 24647689 753aa CG5873 3R Transcript 
CG6969, Cardinal  24649111 830aa CG6969 3R Transcript 
CG10211 19921482 1394aa CG10211 2L Transcript 
Irc  21356609 697aa CG8913 3R Protein (Ha et al. 2005)  
Pxd 45553389 690aa CG3477 3R Transcript 
Pxt 28571758 809aa CG7660 3R Protein (Sritunyalucksana et al. 
2001) 
CG3131 281364292 1537aa CG3131 2L Transcript 
CG12002, Pxn 24656151 1527aa CG12002 3L Transcript 
CG42331 221459132 1615aa CG42331 3R Transcripts 
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Figure 18. Chromosomal location of ten putative Drosophila melanogaster genes. CG10211 and 
CG3131 are located on the left arm of chromosome 2. CG12002 is located on the left arm of chromosome 
3. Irc, CG4009, pxt, pxd, CG5873, CG6969 and CG42331 are located on the right arm of chromosome 3. 
 
Mammalian COX proteins function as homodimers; each monomer contains (1) 
an N-terminal epidermal growth factor domain (EGF), (2) a membrane binding domain 
(MBD) with four amphipathic helices, and (3) a C-terminal catalytic domain of 
approximately 460 residues (Picot, Loll, and Garavito 1994; Luong et al. 1996; 
Kurumbail et al. 1996). Consensus from various domain architecture analysis programs 
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suggests that although all of the D. melanogaster proteins have at least one of the 
signature animal heme peroxidase domains located at the C-terminus (CG10211 is 
unique in housing two animal heme peroxidase domains), the rest of the domain 
architecture in the candidate D. melanogaster proteins bears little resemblance to the 
mammalian counterparts (Figure 19). In addition, none of the D. melanogaster proteins 
appears to have a detectable EGF-like domain at their N-termini. Although typical 
motifs associated with mammalian COX–like membrane domain are not detected in the 
D. melanogaster proteins, secondary structure analysis reveals helical content in their N-
terminal regions raising the possibility that a helical structural domain similar to the 
mammalian COX MBDs may also be present in the fly proteins.  
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Figure 19. Schematic domain architecture of putative cyclooxygenase proteins in Drosophila 
melanogaster. Sequence length and domain position are proportional to actual amino acid sequences.  
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COX genes are conserved across different phylogenetic clades 
including insects 
COXs genes have been found in the genomes of non-mammalian vertebrates, 
invertebrates (Koljak et al. 2001), plants (Sanz, Moreno, and Castresana 1998), bacteria, 
and fungi (Gao et al. 2003). A preliminary phylogenetic analysis of known and putative 
COX enzymes reveals that COX-1 enzymes and COX-2 are clustered into separate 
groups and fungal, bacterial, and insect COXs appear to be quite distant from vertebrate 
COXs, and closer to plant COXs. The existence of COX-2 like genes appears only in 
vertebrate genomes, whereas COX-1 gene is more widespread. The branches for 
bacteria, fungi, arthropods, and vertebrates are distinct, indicating that gene divergence 
of COX-1 and COX-2 occurred relatively early, before the speciation of arthropods 
(Koljak et al. 2001).   
The putative D. melanogaster COXs are quite distinct in sequence from the 
known mammalian COXs, a pattern observed in most other insect genomes that have 
been sequenced except for two mammalian parasitic insects, Pediculus humanus 
corporis and Acyrthosiphon pisum, where the putative enzymes seem to be more closely 
related to mammalian COXs (figure 20). Our phylogenetic analysis suggests that 
although insects have more than one COX–like gene, they all cluster with COX-1, the 
housekeeping enzyme. Sequence and structural analysis detailed below also suggest 
COX-1-like features for the three putative D. melanogaster COXs, including residues 
His207, Tyr385, Tyr388 that are required for peroxidase and cyclooxygenase activities. 
The close proximity of the genes that encode CG4009 and Pxd, and high sequence 
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similarity of CG4009 and Pxd (Figure 18) suggest that they may have arisen from a gene 
duplication event. While all the insect COX homologues are significantly different from 
mammalian COXs from an evolutionary standpoint, all insects genomes analyzed 
(except for Bombyx mori), do possess putative homologous sequences of COX proteins, 
similar to the proteins identified in D. melanogaster.  
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Figure 20. Phylogenetic tree of COX proteins in different organisms. Bootstrap value is labeled at 
every node.  
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Sequence analysis of the candidate protein reveals only three 
of the candidate proteins possess key catalytic and other 
functional residues  
To further scrutinize the candidate proteins for the conservation of key functional 
residues within the protein domains and to identify the hallmarks of COX proteins, we 
built a multiple sequence alignment of the animal heme peroxidase domain of ovine 
COX-1 (oCOX-1) and murine COX-2 (m-COX-2) (structural representatives for 
mammalian COX-1 and COX-2 respectively (Picot, Loll, and Garavito 1994; Kurumbail 
et al. 1996)) with the candidate proteins (table 6). The overall similarity in sequence 
between the seven candidate proteins and oCOX-1/mCOX-2 is low, but there seems to 
be some conservation of key functional residues as shown in table 5. (1) Functionally 
important residues for mammalian cyclooxygenase activity include the catalytic triad of 
His207, Tyr385, and His388, and Arg120, Gln203, Val349 and Ser530 (table 6; 
numbering based on oCOX-1).  Although Arg120 is not housed in the catalytic domain, 
it is known to interact with the substrate arachidonate (Mancini et al. 1995). (2) Gln203 
is conserved in all seven fly COX enzymes but the function of this residue in 
mammalian proteins remains unknown. (3) Val/Leu349 has been suggested to determine 
substrate specificity: All mammalian COXs have Val349 and utilize arachidonic acid as 
substrate, while in some invertebrate COXs, the valine is substituted by a leucine, and 
this changes their substrate specificity towards linoleic acid (Garscha and Oliw 2009). 
(4) Acetylation of Ser530 is the functional basis of inhibition of COX by aspirin (Loll, 
Picot, and Garavito 1995). (5) Alignment of the animal heme peroxidase domain of 
candidate fly COXs and oCOX-1/mCOX-2 reveals that only Pxt, Pxd and CG4009 have 
all three required residues for COX catalytic activity (Figure 21). A preliminary 
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structural modeling of the seven other candidates confirms the absence of the complete 
catalytic signature at the structural level as well (data not shown). (5) All three putative 
D. melanogaster COXs have residues corresponding to Gln203, but none of them have 
the residue corresponding to Arg120 in oCOX-1, located in the oCOX1 MBD. (6) While 
none of the seven fly candidates have a serine that aligns perfectly with mammalian 
Ser530, CG6969, the first of the two animal peroxidase domain of CG10211, CG5873 
and Irc have a serine located in the vicinity of Ser530. (7) All seven D. melanogaster 
proteins have a leucine residue instead of valine at the position corresponding to Val349, 
indicating that D. melanogaster may have a different preferred substrate compared to the 
mammalian COXs. (8) Other striking features include a large insertion of around 60 
residues in the N-terminus in D. melanogaster proteins outside the peroxidase domain. 
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Table 6. Comparison of ten COX candidate proteins from Drosophila melanogaster 
  
Arg120 (interact 
with 
arachidonate) 
Gln203 
(POX) 
His207 
(POX) 
Tyr385 
(COX) 
His388 
(POX) 
Val349/Leu 
substrate 
determination 
Ser530 
(acetylation 
by aspirin) 
CG3131 F T F F T Leu F 
CG4009 F T T T T Leu F 
CG5873 F T T F T Leu F 
CG6969  F T T F T Leu F 
CG10211 
F T F F F Leu F 
F T T F T Leu F 
CG42331 F T T F T Leu F 
Irc F T T T F Leu F 
Pxd F T T T T Leu F 
Pxn F T T F T Leu F 
Pxt F T T T T Leu F 
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Figure 21. Sequence alignment showing conserved important functional residues in the three COX 
candidates.  Pxt, Pxd and CG4009 have the three required residues – His207, Tyr385 and His 388. 
Structure profile of oCOX-1 is obtained from sheep COX-1 (PDB ID 1CQE). Identical/similar residues 
are boxed in red/white. Locations of His207, Tyr385 and His388 are marked with blue arrows.
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Molecular models of the animal peroxidase domains of the 
putative Drosophila COXs predict similarity to mammalian 
COXs. 
To understand the physiochemical properties of all three putative D. 
melanogaster cyclooxygenases, Pxt, Pxd and CG4009 and compare them with the 
mammalian COX enzymes, we built models of their catalytic domains (figure 22 and 
table 7). Structurally, all the three proteins are predicted to maintain the catalytic 
signature in a well–formed and largely hydrophobic catalytic pocket highly similar to 
the mammalian enzymes (figure 23). Pocket residues of CG4009 are Val161, Ile165, 
Thr348, Tyr349, Trp352, Leu353, Phe356, Val357, Glu375, Ser393, Ala396, Phe397, 
Ala400, Phe554, Leu559, Ile562, Gly563, Phe566, Leu567, Thr569 and Arg570. Pocket 
residues of Pxd include Met183, Met187, Ser384, Tyr385, Trp388, Leu389, Phe392, 
Leu393, Tyr412, His428, Ala432, Phe433, Phe436, Ala586, Leu591, Leu594, Thr595, 
Phe598, Tyr599, Thr601 and Arg602. Pocket residues of Pxt contain Leu318, Ile322, 
Thr517, Tyr518, Phe521, Leu522, Ile525, Ile526, Phe559, Ala563, Tyr564, Met566, 
Val713, Ala718, Ile721, Ala722, Phe725, Ala726, Phe728 and Lys729. The pocket 
volumes of CG4009, Pxd and Pxt are 521, 414 and 357 cubic angstroms, respectively, 
similar to the pocket volume of sheep COX-1, which is 344 cubic angstroms. In 
contrast, pocket volume of mouse COX-2, which is 1384 cubic angstroms, is much 
bigger. A structure based sequence alignment of oCOX-1 and the modeled structures of 
the D. melanogaster proteins marginally improves the sequence identity to the range of 
12%-24%, and correspondingly, sequence similarity to 28% -39% over a purely 
sequence based alignment. Insertions in CG4009, Pxt, and Pxd relative to mammalian 
COXs manifest as three extra loops, one of which is located in the proximity of the 
	  76	  
catalytic pocket, changing the shape of the pocket compared to the mammalian COX 
structures.  
 
 
Figure 22. Structural alignment of molecular model of the catalytic animal peroxidase domain of 
Drosophila melanogaster putative COXs and sheep COX-1. Molecular models of the catalytic animal 
peroxidase domain of D. melanogaster putative COXs (silicon) aligned with sheep COX-1 (green, PDB 
code 1CQE). The catalytic residues (His, Tyr and His) are shown as sticks. His 207, Tyr 385 and His 388 
from sheep COX-1 are shown in blue. The corresponding residues from D. melanogaster proteins are 
shown in red. A. Catalytic domain of CG4009 aligned with sheep COX-1. B. Catalytic domain of Pxd 
aligned with sheep COX-1. C. Catalytic domain of Pxt aligned with sheep COX-1 
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Table 7. Result of modeling of the catalytic domain of the three putative D. melanogaster COXs. 
RMSD, Z-score and sequence identity/similarity is based on structural alignment of the conserved domain 
from putative D. melanogaster protein and sheep COX-1 (PDB ID: 1CQE) 
Protein RMSD/Å Sequence Identity Sequence Similarity 
CG4009 2.66 23% 39% 
Pxd 2.85 20% 38% 
Pxt 2.81 24% 37% 
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Figure 23. Comparison of catalytic pocket hydrophobicity in sheep COX-1, Drosophila melanogaster 
CG4009, Pxd and Pxt. Whole subunits were rendered in white mesh except residues forming the cavity. 
Hydrophobic residues are colored in green. Non-hydrophobic residues are colored in white.  A. Catalytic 
pocket of sheep COX-1. Model shown is sheep COX-1 (PDB code: 1CQE). B. Catalytic pocket of 
CG4009. C. Catalytic pocket of Pxd. D. Catalytic pocket of Pxt. E. Sequence alignment based on multi-
structural alignments of sheep COX-1 (oCOX-1) and D. melanogaster proteins showing hydrophobic/non-
hydrophobic residues marked in green/yellow shadow. 
E	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Docking of substrate and heme in the catalytic pocket of the 
modeled animal peroxidase domain of the putative D. 
melanogaster COXs 
Both CG4009 and Pxd possess a largely hydrophobic catalytic substrate pocket 
similar to those in mammalian COXs (W L Smith, DeWitt, and Garavito 2000) to 
accommodate the lipid substrate(s) (Figure 23). We docked the cofactor of COX, heme, 
as well as the lipid substrates in the molecular models of the Drosophila COXs to 
predict if they mimic the mammalian COXs in their binding orientation and satisfy the 
constraints to undergo catalysis. Based on the leucine substitution corresponding to the 
Val349 of oCOX-1 in the D. melanogaster COXs, we also docked linoleic acid in 
addition to the canonical COX substrate, arachidonic acid and compared their fit in the 
catalytic pocket, binding orientation and suitability as a substrate. We successfully 
docked both linoleic acid (data not shown) and arachidonic acid into the catalytic pocket 
in all three putative D. melanogaster peroxidase domains. The C-13 of the docked 
arachidonic acid and the phenolic oxygen of catalytic tyrosine in CG4009 are in close 
vicinity (figure 24B), suggesting the theoretical possibility for the reaction to occur. 
Docking of arachidonic acid in the catalytic pocket of Pxd and Pxt also suggest the same 
(figure 24C and D). The distance between the C-13 of arachidonic acid and the oxygen 
of Tyr 399 in CG4009 is 3.8 Å, and for Pxd, the C-13 of arachidonic acid is positioned 
2.6 Å from the oxygen of Tyr 435, and for Pxt, the distance between the C-13 of 
arachidonic acid and the oxygen of Tyr 564 in CG4009 is 3.5 Å.  
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Figure 24. Docking of heme and arachidonic acid into the conserved domain of D. melanogaster 
COXs. Protein structures are rendered in cartoon in green color. Heme B is shown in red. Arachidonic 
acid is shown in pink. Catalytic residues are shown in blue. Gln203 and equivalents are shown in purple. 
Val349 and equivalents are shown in orange. Ser530 and equivalents are shown in cyan.  
A. Structure of sheep COX-1 (Protein Data Bank code: 1DIY) shows the position of arachidonic acid and 
important residues. B-D. Computationally generated structures of the conserved catalytic domain from D. 
melanogaster proteins: CG4009, Pxd and Pxt. 
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Predicted subcellular localization of putative D. melanogaster 
COXs 
COX proteins are primarily thought to be membrane-associated proteins. 
Homodimers of COX are thought to be located at the luminal side of the membrane of 
the endoplasmic reticulum and of the inner and outer membranes of the nuclear 
envelope (Otto and Smith 1994; Morita et al. 1995; Andrew G. Spencer et al. 1998), and 
anchor to the membrane via a MBD, which consists of four amphipathic helices of 50 
amino acids. In comparison, both Pxd and CG4009 are predicted to have a single 
transmembrane domain each at their N-terminus, part of which encompasses a signal 
peptide motif (figure 25). It is uncertain if the signal sequence is cleaved and results in a 
partially cleaved transmembrane domain.  On the other hand, the Pxt sequence does not 
show any characteristic features of a membrane–binding domain in its N-terminal 
region. Preliminary full length modeling based on combined template-based and ab 
initio approaches suggest that N-terminal region outside of catalytic domain in Pxd, Pxt, 
and CG4009 form structured helical regions that may manifest as independent domains 
similar to the MBD in oCOX-1 or integrate with the catalytic domain (figure 26). 
Mammalian COXs have a N-terminal 16 amino acids signal peptide for secretion, and it 
is translated and then cleaved by microsomal signal peptidase (Picot, Loll, and Garavito 
1994). All three putative D. melanogaster COXs are predicted to have signal peptides 
for secretion similar to the mammalian COXs although divergent in sequence (figure 
25). 
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Figure 25. Sequence alignment of signal peptides from putative D. melanogaster COXs and human 
COX-1, COX-2, sheep COX-1 and mouse COX-2. Identical/similar residues are colored in red/white. 
 
 
Figure 26. Full-length models of CG4009, Pxd and Pxt show that the N-termini of the proteins are 
similar to MBD in mammalian COXs. Full-length models built by I-tasser are rendered in cartoon. Blue 
regions are catalytic domains. Red regions are N-termini. Green regions are C-termini. A. sheep COX-1 
(PDB ID: 1CQE). B.CG4009. C. Pxd. D. Pxt 
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COX activity assay 
We used y w, pxtf01000/+ and pxtf01000/f01000 female and male flies to compare 
changes in COX activity in wild type and pxt mutant flies. y w files are wild-type flies 
that are used as the control group. pxtf01000 is a mutant allele of pxt, which contains a 
Piggybac insertion within the 5’ UTR. The insertion is located 38 bp upstream of the 
start codon (Thibault et al. 2004). Tootle et al. confirmed that transcriptional expression 
level of pxt is significantly lower in the whole pxtf01000/f01000 fly (Tootle and Spradling 
2008). 
 We standardized COX activity in all the flies by setting the COX activity level in 
y w female flies as 100%. We performed paired two-tailed t-tests using Excel to verify 
whether the three repetitions of experiments are significantly different. The p (T<=t) 
values of three tests were 0.40, 012 and 0.11, which indicates that the data from three 
repetitions were not statistically different. Our preliminary results (figure 27) show that 
despite the noise (standard errors are marked in figure 27) in our activity assay there is a 
trend in COX activity in homozygous pxtf01000/f01000 flies being lower than y w flies. In 
female pxtf01000/f01000 flies, COX level is 50% of that in y w female flies; and in male 
pxtf01000/f01000 flies, COX activity level is 40% lower than y w male flies. However, 
heterozygous male and female pxtf01000/f01000 flies do not differ from y w male and female 
flies in COX activity level. In order to establish a clear link of COX activity associated 
with Pxt, further experiments would be required.  
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Figure 27. COX activity level in y w, pxtf01000/+, and pxtf01000/f01000 flies 
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Discussion 
The major predictions of our studies are that Pxt, Pxd and CG4009 are highly 
likely to function as COX-like enzymes. All three proteins contain the conserved 
functionally crucial catalytic residues His207, Tyr385 and His388 found in mammalian 
COXs, suggesting their capability to catalyze the reaction that converts PUFAs to 
prostaglandins. The core structural fold of the conserved animal peroxidase domain is 
maintained in these proteins, and the biophysical features of the catalytic cavity mimic 
that of structurally solved mammalian COXs. The catalytic pocket of mammalian COX 
is L-shaped and largely hydrophobic; among the 24 residues that make up the catalytic 
pocket, only three are polar, and 21 are non-polar in human COX-1 and 2; the catalytic 
pockets of CG4009, Pxd, and Pxt follow a similar hydrophobic profile. All Drosophila 
COX proteins seem to be missing the mammalian MBD, which consists of four beta 
sheets and the last of which also forms a structural component of the catalytic cavity. A 
functionally important residue, Arg120, resides in this region and interacts with the 
carboxylate group of arachidonate through its arginine group (Bhattacharyya et al. 1996; 
Mancini et al. 1995). Pxd, Pxt and CG4009 do not have a direct counterpart for Arg120 
in the primary structure, but Arg150 in CG4009 and Arg520 in Pxt could be envisioned 
to play a similar role. CG4009 also has Glu546 positioned on the opposing Arg150 and 
may be involved in forming a salt bridge when substrate in not present as proposed for 
Arg120 and Glu524 in oCOX-1 (Bhattacharyya et al. 1996; Mancini et al. 1995). 
Other functionally important residues identified in the mammalian COXs include 
Glu203, Ser530 and Val349. Glu203 is important for the peroxidase activity of the 
	  86	  
enzyme and mutating this residues reduces enzyme activity (Shimokawa et al. 1990; 
Shimokawa and Smith 1991; Landino et al. 1997). All three Drosophila proteins possess 
this conserved glutamine residue in the expected structural context. Ser530, the residue 
that is acetylated by aspirin and plays a critical role in aspirin mediated COX inhibition, 
is missing in all Drosophila COX candidates. However, CG4009 has a different serine 
residue, Ser393 in the catalytic pocket in the modeled catalytic domain. Although the 
serine does not align with Ser530 in mammals in the multiple sequence alignment, it 
presents in a similar structural context as the mammalian Ser530. This suggests that 
action of aspirin on Drosophila COXs may involve a different mechanism than the 
conventional acetylation of Ser530, or proceeds through the acetylation of Ser393 in 
CG4009. The role of Val349, which is present in the substrate binding channel, is more 
subtle; replacement of Val349 to isoleucine results in a change in stereochemistry of the 
product formed to 15R-configuration prostaglandins (Schneider et al. 2002), but 
substitutions with leucine affect substrate specificity changing preference from 
arachidonic acid to linoleic acid (Garscha and Oliw 2009). Previous research (Yoshioka 
et al. 1985; L. R. Shen et al. 2010) has shown D. melanogaster lacks C20 and C22 
polyunsaturated fatty acids, including arachidonic acid in body tissues of larvae, pupae 
and adults, as well as the machinery to extend C18 fatty acids to C20 fatty acids (David 
W. Stanley-Samuelson et al. 1988). The leucine substitution corresponding to Val349 
may be indicative of a preference of Drosohila Cyclooxygenase(s) to use linoleic acid as 
substrate. Our docking analysis, however, suggests that if arachidonic acid is available 
as a substrate, the substrate binding channel of CG4009, Pxd and Pxt can accommodate 
it and theoretically should be able to use it to generate prostaglandins. If indeed linoleic 
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acid is key substrate being utilized, then we expect to see hydroxyoctadecadienoic acids 
(HODEs) as the major products of CG4009, Pxd and Pxt. Further experimental studies 
can be designed to test our theoretical predictions to validate the substrate binding 
preferences as well as the capability of wild type flies/flies overexpressing 
CG4009/Pxd/Pxt to generate PGs if fed with a diet enriched with AA. A full profile of 
mass spectra of eicosanoid products from wild type, CG4009/Pxd/Pxt 
knockout/knockdown flies and flies overexpressing CG4009/Pxd/Pxt maybe be a useful 
indicator towards clues as to the preferred substrate of CG4009/Pxd/Pxt, which 
theoretically possess the capability of both cyclooxygenase and peroxidase catalytic 
activity. 
Even though multiple COX candidates seem to exist in Drosophila, our 
preliminary analysis of the evolutionary origins of the sequences suggests that none of 
them clusters preferentially with COX-2. Mammalian COX-1 and COX-2 are very 
similar in sequence, sharing 60% sequence identity and virtually superimposable 
structures of their catalytic domains, but there are specific differences in some key 
residues lining the catalytic pocket and the volume occupied by the pockets that account 
for differences in substrate binding and affinity (Sharma et al. 2010; Yuan et al. 2009). 
A more select comparison of the key residues responsible for COX-1/COX-2 differences 
does not shed any further light, since the Drosophila sequences are quite different from 
the mammalian COXs. However, the sizes of the catalytic pocket for CG4009, Pxd and 
Pxt are much closer to that of the smaller pocket of COX-1. The existence of multiple 
COX-like sequences that do not correspond to a distinct COX-1/COX-2 type of lineage 
suggests that they may have arisen from gene-duplication events independent from those 
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that produced vertebrate COX-1 and COX-2; this seems highly plausible for CG4009, 
Pxd and Pxt since the locations of the genes on the genome are very close. It can be 
speculated that the multiple COXs code for either a functional redundancy or difference 
in function based on different expressional pattern. All three genes exist at transcript 
level based on EST analysis (Kalajdzic et al. 2012), and the anatomical and 
developmental expression level of these genes is quite distinct. Microarray studies 
suggest that whereas CG4009 is expressed only when flies reach adulthood, pxt 
expression peaks before the embryo reaches 6hr and is also high in adults (Chintapalli, 
Wang, and Dow 2007). Expression level of pxd has several peaks: during embryo 14-
20hr, pupae 3 days and carcass (Chintapalli, Wang, and Dow 2007). pxd has high 
expression level in the fat body; CG4009 has moderately high expression in ovary in 
adult female flies, and pxt has extremely high expression in embryos and ovary in adult 
female flies (Chintapalli, Wang, and Dow 2007). 
Structural analyses elucidate the mechanism for membrane binding for 
mammalian COX proteins (Picot, Loll, and Garavito 1994) and suggest their localization 
at membranes. Studies focusing on sub-cellular localization of mammalian COXs 
suggest that it predominantly located in ER/NE/Golgi system, but there are studies 
indicating that occasionally COX may be found both at the plasma membrane and 
cytosol (Yamashita et al. 2007; Koumas and Phipps 2002; Leclerc et al. 2008). 
Experimental studies following the cellular localization of COXs also show that COXs 
are both cytosolic and membrane-associated (Koumas and Phipps 2002; Yamashita et al. 
2007; Perrone et al. 2007), and kinetics studies show that both microsomal and purified 
soluble proteins have the same Km using arachidonic acid as the substrate, indicating 
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that membrane-bound and soluble COXs behave in a similar way (Kulmacz, Pendleton, 
and Lands 1994). Additionally, it is known that the subcellular localization of COX is 
altered with changes in physical condition such as in cancer cells and treatment with 
various reagents such as heat-killed Mycobacterium bovis BCG. (Koumas and Phipps 
2002; Roos and Simmons 2005; Perrone et al. 2007; Yamashita et al. 2007; Accioly et 
al. 2008; Leclerc et al. 2008; García-Bueno, Serrats, and Sawchenko 2009). Several 
sequence and structural features are suggested to contribute to the targeting mechanism 
of COXs to their correct subcellular compartment: signal peptides, membrane-binding 
domain, glycosylation sites, EGF-like domain and KDEL-like peptide (P/STEL in 
COX). The putative Drosophila COXs, CG4009, Pxd and Pxt all have signal peptide 
shared by proteins that are membrane resident or secreted. Even though the Drosophila 
sequences are distinctly missing the MBD, the N-terminus is not predicted to be 
unstructured.  The preliminary full-length computational models suggest compact helical 
domains that associate with the catalytic domain with an overall hydrophobic and could 
serve as analogous membrane binding structures (data not shown). Some sequence 
features of mammalian cyclooxygenases such as N-glycosylation sites, and KDEL-like 
retention signal (P/STEL in COXs) are not apparent in the Drosophila sequences and 
would be worth investigating further experimentally if the Drosophila COXs parallel the 
mammalian COXs in glycosylation patterns and organelle retention possibly using 
divergent sequence signals. 
We show that despite being quite divergent in sequence, the 3 putative COXs of 
Drosophila possess the same inherent enzymatic fold and components of domain 
architecture that would allow them to function in a very similar manner as mammalian 
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COXs. Out of the three candidates, CG4009 possess the most vertebrate COX-like 
features, but we suggest that all 3 proteins are capable of catalyzing enzymatic reactions 
characteristic of COX proteins. The preliminary COX activity assays for pxt mutants 
corroborate this prediction. Our findings raise some exciting and pertinent questions 
about the substrate requirements of all 3 proteins and the implications of downstream 
products being formed in Drosophila eicosanoid signaling.  This study lays the 
groundwork for further exploration of these proteins and establishing their role in 
Drosophila inflammation and immunity, opening up avenues for addressing the use of 
this model organism in COX signaling and its crosstalk with other signaling pathways. 
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Chapter 5 Prostaglandin E Synthases in Drosophila 
melanogaster 
Prostaglandin E Synthase-1 (PGES-1/mPGES-1) 
Microsomal prostaglandin E synthase-1 (PGES-1/mPGES-1) is a downstream 
enzyme of COXs (COX-1/2).  
Based on BLAST results, three genes CG33177, CG33178 and mgsl 
(microsomal glutathione S-tranferase-like, CG1742) in D. melanogaster genome encode 
four proteins that share sequence similarity with human PGES-1. Gene mgsl encodes 
two proteins: Mgsl isoform A and Mgsl isoform B due to alternative splicing. All the 
three genes are located on the D. melanogaster X chromosome. Residues that are crucial 
for enzyme activity include Glu66, Arg67, Arg70, Arg72, Arg100 and Tyr117, and all 
the residues are conserved in the three D. melanogaster proteins. In hPGES-1, residues 
required for GSH binding include Tyr117, Arg126, Tyr130 and Gln134. All the three 
proteins, Mgsl, CG33177 and CG33178 have the conserved Tyr117 and Arg126, but are 
missing Tyr130 and Gln134. In all the three D. melanogaster proteins, Tyr130 is 
replaced by a Phe. In CG33177, Gln134 is replaced by a Phe, but in CG33178 and Mgsl, 
the Gln is replaced by a Leu (Table 8; figure 28).  
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Table 8. Comparison of three PGES-1 homologues in D. melanogaster 
Protein Name Length Accession No. Chromosome CG no. 
Seq Identity 
with hPGES1 
Seq Similarity 
with hPGES1 
No of Transmembrane 
domain 
Mgsl isoform A  152aa NP_524696 X, 19E7-19E7 CG1742 33% 54% 4 
CG33177 167aa NP_788903.1 
X, 13A9-
13A9 CG33177 28% 49% 3 
CG33178 165aa NP_788904.1 
X, 13A9-
13A9 CG33178 30% 46% 3 
 
 
 
Figure 28. Sequence alignment of hPGES-1 and D. melanogaster proteins CG33177, 
CG33178, Mgsl isoform A and Mgsl isoform B. Secondary structure of hPGES-1 is based on the crystal 
structure of hPEGS-1 (PDB ID: 3DWW). Residues that share identity/similarity are boxed in red/white. 
Regions colored in yellow are glutathione-binding regions. Green-circled residues are glutathione-binding 
residues. Blue arrows indicate residues that are important for enzymatic reaction. 
  
	  93	  
The secondary structure analysis shows that the four proteins are mostly helical, 
similar to human PGES-1. All the four proteins are predicted to have four 
transmembrane domains, similar to human PGES-1. Human PGES-1 has four 
transmembrane domains even though it has six helices, because the first and the second 
helices constitute the first transmembrane helix and the fifth and the six helices make up 
the fourth transmembrane helix (figure 29 and figure30). 
 
 
Figure 29. Conserved domain of human PGES-1, D. melanogaster proteins Mgsl, CG33177 and 
CG33178. Red rectangles represent MAPEG domains. Blue rectangles represent transmembrane helices.  
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Figure 30. Structural alignment of hPGES-1 (PDB ID: 3DWW) and D. melanogaster proteins 
CG33177, CG33178 and Mgsl. Proteins are rendered in cartoon. hPGES-1 is shown in pink, and D. 
melanogaster proteins are shown in olive. Glutathione is shown as red sticks. In hPGES-1, glutathione-
binding regions are colored in yellow. Glutathione-binding residues are shown in green. Other important 
residues are shown in blue. In D. melanogaster proteins, glutathione-binding regions are colored in 
orange. Glutathione-binding residues are shown in cyan. Other important residues are shown in purple. 
A. Structural alignment of hPGES-1 and CG33177. B. Structural alignment of hPGES-1 and CG33178. C. 
Structural alignment of hPGES-1 and Mgsl.  
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Prostaglandin E Synthase-2 (PGES-2/mPGES-2) 
We identified one protein, suppressor of ref(2)P sterility (CG4086, Su(2)P), in 
the D. melanogaster genome that shares sequence similarity and identity with monkey 
PGES-2. Monkey PGES-2, which has 377 amino acids, has two conserved domains, one 
glutathione S-transferase N-terminal region (GST_N) ranging from residue 90 to 193, 
and one glutathione S-transferase C-terminal region (GST_C), ranging from residue 263 
to residue 377. Putative D. melanogaster PGES-2 Su(2)P has 417 amino acids, and 
similar to hPGES-2, it is predicted to have two conserved domains, GST_N and GST_C. 
GST_N domain in D. melanogaster Su(2)P ranges from residue 110 to 219, and GST_C 
domain in D. melanogaster Su(2)P is located from residue 287 to 399 (Figure 32). 
Monkey and D. melanogaster PGES-2 share 34% sequence identity and 50% 
sequence similarity (figure 31). Important residues for monkey PGES-2 include residues 
that are involved in hydrogen bonding and glutathione binding. Residues that are 
involved in hydrogen bonding include Tyr104, Cys110, Phe112 and Cys113. D. 
melanogaster Su(2)P has all the equivalents except Tyr104. In D. melanogaster Su(2)P, 
Tyr104 is replaced by a Phe. The equivalent residues for monkey PGES-2 Cys110, 
Phe112 and Cys113 are Cys113, Phe135 and C136 in D. melanogaster Su(2)P. The 
residues that are involved in glutathione binding in monkey PGES-2 are Val148, 
Asp163 and Ser165, and D. melanogaster Su(2)P has equivalents for all the three 
residues: Val171, Asp164 and Ser165 (table 9). 
We built a 3D structural model for the D. melanogaster Su(2)P conserved 
domain, which includes the two conserved domains, GST_N and GST_C, from residue 
110 to residue 399, using monkey PGES-2 (PDB ID: 1Z9H) as structural template. 
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Monkey and D. melanogaster PGES-2 conserved domains have very similar structural 
folds with RMSD 0.6Å, Z-score 7.6 and sequence identity 42.8% (figure 33). The 
residues that are involved in glutathione-binding in the two proteins have similar 
locations and orientation.  
 
Table 9. Comparison of important residues that are involved in hydrogen bond formation and 
GSH-binding in monkey PGES-2 and putative D. melanogaster PGES-2. 
  H-bond chain GSH-binding 
Monkey 
PGES-2 Y107 
C110 
Catalytic activity F112 C113 V148 D164 S165 
dPGES-2 F130 133 135 136 171 188 189 
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Figure 31. Sequence alignment of monkey PGES-2 and D. melanogaster suppressor of ref(2)P 
sterility. 
Secondary structure of hPGES-1 is obtained from PDB 1Z9H. 
Similar/identical residues are boxed in white/red boxes. Green circles show residues required for 
glutathione binding  (V148, D164 and S165). Purple arrows indicate important residue required for 
catalytic activity (110C). Blue arrows indicate the characteristic H-bond chain formation (Y107-C113-
C110-F112). 
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Figure 32. Conserved domain of monkey PGES-2 and D. melanogaster suppressor of ref(2)P 
sterility. Purple rectangles represent glutathione S-transferase N-terminal region (GST_N). Green 
rectangles represent glutathione S-transferase C-ternimal region (GST_C). 
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Figure 33. Structural alignment of conserved domain of monkey PGES-2 (PDB code: 1Z9H) and D. 
melanogaster suppressor of ref(2)P sterility. 
Monkey PGES-2 is shown in pink. D. melanogaster suppressor of ref(2)P sterility is shown in olive.  
For monkey PGES-2: four residues (Y107, C110, F112, C113) that form H-bond chain are shown as blue 
sticks, and three residues (V148, D164, S165) that are involved in glutathione-binding are shown as green 
sticks.  
For D. melanogaster suppressor of ref(2)P sterility: four residues (F130, C133, F135, C136) that form H-
bond chain are shown as purple sticks, and three residues (V171, D188, S189) that are involved in 
glutathione-binding are shown as cyan sticks.  
Glutathione molecule is shown as red sticks. 
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Prostaglandin E Synthase-3 (PGES-3/cPGES) 
We identified one putative PGES-3 in D. melanogaster, CG16817. Similar to 
mammalian PGES-3, the secondary structure of CG16817 consists of mostly beta-sheet. 
Sequence identity/similarity between the two proteins is 24%/41% (figure 34).  
 
Figure 34. Sequence alignment of human PGES-3 and D. melanogaster protein CG16817.  
Secondary structure shown above the sequences is obtained from Protein Data Bank from crystal structure 
of the human co-chaperon p23 (PDB code 1EJF). Eight beta sheets are shown and numbered. 
Similar/identical residues are boxed in white/red.  
 
Human PGES-3 is 160 amino acids long. The crystallized structure of human 
PGES-3 (PDB ID: 1EJF) includes residues 1-110. Human PGES-3 has eight beta sheets. 
The functional domain in human PGES-3 is co-chaperone p23 domain, also called CS 
domain (CHORD-containing proteins and SGT1 domain), which ranges from residues 
1-110, and this conserved domain includes all the eight beta sheets. According to 
prediction by multiple servers, CG16817 also is composed of eight beta sheets, in 
addition to an extra C-terminal alpha helix. Conserved p23 domain in CG16817 is made 
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up with the eight N-terminal beta sheets, ranging from residue 1 to 120 (figure 35 and 
figure 36). 
 
Figure 35. Conserved domain of hPGES-3 and D. melanogaster CG16817.  
 
 
Figure 36. Secondary structure of putative D. melanogaster PGES-2 (CG16817). 
Secondary structure of CG16817 is calculated by four servers: psipred, jpred, prof, and APSSP2. 
Beta sheets are shaded in yellow color, and alpha helices are shaded in red color. 
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We have built a three-dimensional structural model of the conserved p23/CS 
domain of CG16817 using human PGES-3 (PDB ID: 1EJF) as the structural template 
and alignment generated by HHpred. The structural alignment of the conserved CS 
domains from the two proteins has RMSD 2.94 Å, Z-score 6.35, and sequence identity 
25% (figure 37).  
 
Figure 37. Structural alignment of hPGES-3 and D. melanogaster CG16817. Proteins are represented 
in cartoon. hPGES (PDB code 1EJF) is shown in green. p23/CS domain of CG16817 (residues 1-120) is 
shown in blue. 
 
Currently, there has not been any solved PGES-3 structure with co-factor GSH 
bound. Therefore, to compare and analyze the GSH-binding structural motifs of hPGES-
3 and D. melanogaster CG16817, we docked GSH onto the predicted model of D. 
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melanogaster CG16817 and hPGES-3 (PDB ID: 1EJF) (figure 38) and show that the 
GSH binding motifs are similar in the two proteins. Based on our docking results we 
identified that Trp8, Arg88, Thr90, Glu92, Arg93, Ala94, Lys95, Leu96, Asn97, Trp98, 
Leu99, Ser100 and Val101 of hPGES-3, and Trp14, Ser93, Ser94, Leu95, Thr96, Asp98, 
Lys99, Thr100, Lys101, Leu102, His103 and Leu105 of CG16817 are involved in GSH-
binding (figure 38). GSH-binding motifs of the two proteins are closely related on both 
primary sequence and 3D structures (figure 39). 
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Figure 38. Docking of GSH on hPGES-3 and CG16817 showing that the GSH binding motifs are 
similar in the two proteins. GSH is shown as red sticks. hPGES is rendered in green cartoon, and 
CG16817 is rendered in purple cartoon. hPGES-3 residues involved in GSH-binding are shown as blue 
sticks. CG16817 residues that bind to GSH are shown as yellow sticks. A. hPGES-3 (PDB ID 1EJF). B. 
D. melanogaster CG16817. 
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Figure 39. Sequence alignment of hPGES-3 and CG16817 showing the GSH-binding motifs. 
Residues predicted to be involved in GSH-binding are marked in purple shadow.
	  106	  
Discussion 
In our studies, we predict that the three PGES-1 homologues, CG33177, 
CG33178 and Mgsl are highly likely to function as PGES-1 enzyme. All three proteins 
have the signature multi-transmembrane domains and conserved GSH-binding regions 
(Tyr117, Arg126, Tyr130 and Gln134) that exist in mammalian PGES-1, suggesting the 
three proteins are capable of utilizing GSH as a cofactor, and each isozyme should be 
able to catalyze the reaction that converts PGH2 into PGE2. The computational 3D 
structures of the conserved MAPEG domain in the three proteins are highly similar to 
human PGES-1, and all three D. melanogaster proteins have the conserved catalytic 
motif (Glu66, Arg67, Arg70, Arg72, Arg100 and Tyr117) similar to that of human 
PGES-1. 
Our computational studies of D. melanogaster protein Su(2)P show that Su(2)P 
and monkey PGES-2 are highly similar at both sequence level (34% sequence identity 
and 50% similarity) and structural level (RMSD 0.6Å). D. melanogaster protein Su(2)P 
contains that signature H-bond chain required for catalytic activity in human PGES-2, 
which consists of Tyr107, Cys110, Phe112 and Cys113. Also, GSH-binding residues, 
Val148, Asp164 and Ser165, are conserved in human PGES-2 and D. melanogaster 
Su(2)P, suggesting that D. melanogaster protein Su(2)P is likely to function as a PGES-
2. 
Our prediction shows that CG16817 has the capability to function as a PGES-3 
enzyme. The sequence of the catalytic domain is highly conserved in human PGES-3 
and CG16817. The docking results of cofactor GSH show that the two proteins have 
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similar GSH-binding residues, suggesting that CG16817 is highly likely to function as 
PGES-3.  
In mammals, all three PGESs are involved in the biosynthesis of PGE2, but they 
are expressed in different tissues and under different conditions. PGES-1 is coupled with 
COX-2 and various pathogens induce its expression, while PGES-3 is ubiquitously 
expressed and coupled with COX-1. PGES-2 couples with either COX-1 or COX-2.  
Three PGES-1 homologues, CG33177, CG33178 and Mgsl are proteins that 
share high sequence identity, and all three of them are located on X chromosome within 
close proximity. It is highly likely that the emergence of the three genes is due to a gene 
duplication event.  
Mammalian PGES-1 belongs to MAPGE superfamily, which includes six 
transmembrane proteins: PGES-1, leukotriene C4 synthase (LTC4S), 5-lipoxygenase 
activating protein (FLAP), microsomal glutathione S-transferase 1 (MGST-1), MGST-2 
and MGST-3. All the six members of MAPGES superfamily use GSH as their cofactor 
(Martinez Molina, Eshaghi, and Nordlund 2008). To our knowledge, structures of four 
out of six MAPGE superfamily members were solved. The four crystallized structures 
are human PGES-1 (PDB code: 3DWW, Jegerschöld et al. 2008), rat MGST1 (PDB 
code: 2H8A, Holm et al. 2006), human LTC4S (PDB code: 2UUH, 2UUI, 2PNO, Ago et 
al. 2007; Martinez Molina et al. 2007) and human FLAP (PDB code: 2Q7M, 2Q7R, 
Ferguson et al. 2007). To date, no crystallized structure of non-mammalian MAPGE 
proteins has been published. Our studies are the first to identify a MAPGE superfamily 
member in D. melanogaster. 
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High-throughput expression data in FlyAtlas anatomy microarray shows that 
Mgsl has low expression level in larvae, and it is highly expressed in head, eye, hindgut, 
fat body and heart in adult tissues. The expression levels of CG33177 in larval and adult 
tissues are similar, and CG33177 is moderately expressed in various types of tissues. 
CG33178 is highly expressed in adult crop, head, eye and hindgut and larval trachea. 
PGES-2 homologue Su(2)P is ubiquitously expressed in all adult and larval tissues at 
moderate level, indicating it is more involved in development instead of immune 
response, similar to human PGES-2. PGES-3 homologue CG16817 is ubiquitously 
expressed in all adult and larval tissue at high level, indicating that it is more involved in 
maintaining homeostasis, similar to the function of its counterpart PGES-3 in human.  
Recently, Yamamoto et al discovered that a Bombyx mori sigma-class 
glutathione transferase exhibits prostaglandin E synthase activity (K. Yamamoto et al. 
2013). This Bombyx mori sigma-class glutathione transferase (bmGSTu) shares much 
higher sequence identity with mammalian PGDS (32.4% identity with rat PGDS) than 
PGES-1 (12.7% identity with human PGES-1) or PGES-3 (8.3% identity with human 
PGES-3), but when incubated with PGH2, it exhibits prostaglandin E synthase activity 
rather than prostaglandin D synthase activity (K. Yamamoto et al. 2013). This discovery 
suggests that perhaps enzymes that are involved in prostaglandin synthesis in insects 
may act differently from those in mammals.  
 Our studies identified homologous enzymes of all three types of PGESs in D. 
melanogaster. D. melanogaster PGESs and human PGESs are highly similar in primary 
sequences, and the comparative modeling in our studies suggests that they have very 
similar structural folds. We demonstrate that all putative D. melanogaster PGESs 
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possess the same essential enzymatic structures and key residues, and closely related 
domain architectures that will enable them to catalyze the same reaction that converts 
PGH2 into PGE2 in a similar manner as the mammalian PGESs. Our studies suggests 
that PGE2 biosynthesis mechanism in D. melanogasteis similar to PGE2 synthesis in 
mammals, indicating the possibility of using D. melanogaster in studying physiological 
and pathophysiological processes that involve PGE2.  
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Chapter 6 Conclusions and future directions 
D. melanogaster has served well as a model organism to dissect signaling 
mechanisms governing developmental processes that underlie human disease. A fly 
model with hallmarks of acute and chronic mammalian inflammatory responses will be 
highly useful in understanding how signaling networks and feedback regulatory 
mechanisms are involved in chronic inflammation. Despite the knowledge that lipid 
mediators can modulate immunity in insects, the biochemical nature of eicosanoids, the 
enzymes essential for their biosynthesis, and their role in innate immunity remains 
uncharacterized. The characterization of these pathways in D. melanogaster will 
enhance the mechanistic understanding of the underlying biology in mammalian models 
and underlies our attempt to chart out the components of the COX pathway with detailed 
functional characterization using computational tools. 
Our findings from a preliminary sequence-based scan identified the majority of 
the components of COX pathway in D. melanogaster. This work is the first description 
of the pathway essential for prostaglandin biosynthesis in any invertebrate.  
Detailed comparative modeling and functional characterization of two enzymes 
of this pathway, COX and PGES reveal that despite overall low sequence similarity, D. 
melanogaster enzymes possess similar structural folds and the catalytic motifs that 
characterize their mammalian counterparts, which is consistent with previous findings 
that prove the existence and important biological functions of prostaglandin. Our studies 
build a preliminary foundation for future studies of prostaglandin biosynthesis in D. 
melanogaster.  
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 Our studies show that D. melanogaster proteins CG4009, Pxd and Pxt are all 
COX-like enzymes. All three of them (1) have the key catalytic residues, His207, 
Tyr385 and His388, which are required for the dual peroxidase and cyclooxygenase 
functions, and (2) have a L-shaped mostly hydrophobic catalytic cavity that is required 
to hold the unsaturated fatty acid substrate. A Leu349->Val replacement suggests that 
Pxd and CG4009 may prefer linoleic acid instead of arachidonic acid as a substrate. The 
small substrate-binding cavity of Pxt raises new and intriguing questions regarding its 
substrate(s). 
 We have identified D. melanogaster homologues of all the three PGES in 
mammals, PGES-1, PGES-2 and PGES-3. Functional characterization of the D. 
melanogaster PGESs show that the D. melanogaster and mammalian PGESs are 
structurally conserved and share similar enzymatic structures and key catalytic residues. 
D. melanogaster PGES-1 candidates Mgsl, CG33177 and CG33178 possess the 
signature GSH-binding residues and key catalytic residues. Su(2)P, the only putative D. 
melanogaster PGES-2, is highly similar to mammalian PGES-2 at both primary 
sequence and structural levels, and possesses the functional catalytic residue Cys110. 
The molecular mechanism of the catalytic reaction of hPGES-3 is not well studied, but 
our finding showed that CG16817, the sole putative PGES-3 in D. melanogaster, shares 
similar GSH-binding motifs as hPGES-3.  
 Our studies show that the prostaglandin synthesis pathway in D. melanogaster 
largely parallels mammalian COX pathway: (1) D. melanogaster has the majority of the 
enzymes involved in mammalian prostaglandin biosynthesis pathway; (2) D. 
melanogaster enzymes and mammalian counterparts are similar in amino acid sequence 
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level and structural level; (3) D. melanogaster enzymes have the same catalytic motifs 
of their mammalian equivalents; suggesting the possibility of using D. melanogaster as a 
model organism for studying eicosanoid biosynthesis pathway and 
physiological/pathophysiological processes that involve prostaglandins. Even though the 
putative D. melanogaster COX proteins do not share high sequence similarity and 
identity with the mammalian counterparts, the highly conserved downstream enzymes 
PGES in D. melanogaster suggest that prostaglandin synthesis in D. melanogaster 
parallels the mammalian pathway. 
COX and PGES are targets of anti-inflammatory drugs in pharmaceutical 
research, and our studies unveil the possibility of using D. melanogaster for screening 
novel inhibitors of COX and PGES.  
 
  
	  113	  
References 
Accioly, Maria T, Patricia Pacheco, Clarissa M Maya-Monteiro, Nina Carrossini, Bruno 
K Robbs, Silvia S Oliveira, Cristiane Kaufmann, José A Morgado-Diaz, Patricia 
T Bozza, and João P B Viola. 2008. “Lipid Bodies Are Reservoirs of 
Cyclooxygenase-2 and Sites of Prostaglandin-E2 Synthesis in Colon Cancer 
Cells.” Cancer Research 68 (6) (March 15): 1732–1740. doi:10.1158/0008-
5472.CAN-07-1999. 
Agianian, Bogos, Jonathan D. Clayton, Kevin Leonard, Paul Tucker, Belinda Bullard, 
and Piet Gros. 2001. “Crystallization and Preliminary X-Ray Analysis of 
Drosophila Glutathione S-Transferase-2.” Acta Crystallographica Section D 
Biological Crystallography 57 (5) (April 24): 725–727. 
doi:10.1107/S0907444901003110. 
Agianian, Bogos, Paul A Tucker, Arie Schouten, Kevin Leonard, Belinda Bullard, and 
Piet Gros. 2003. “Structure of a Drosophila Sigma Class Glutathione S-
Transferase Reveals a Novel Active Site Topography Suited for Lipid 
Peroxidation Products.” Journal of Molecular Biology 326 (1) (February 7): 
151–165. doi:10.1016/S0022-2836(02)01327-X. 
Ago, Hideo, Yoshihide Kanaoka, Daisuke Irikura, Bing K Lam, Tatsuro Shimamura, K 
Frank Austen, and Masashi Miyano. 2007. “Crystal Structure of a Human 
Membrane Protein Involved in Cysteinyl Leukotriene Biosynthesis.” Nature 448 
(7153) (August 2): 609–612. doi:10.1038/nature05936. 
Altschul, S F, W Gish, W Miller, E W Myers, and D J Lipman. 1990. “Basic Local 
Alignment Search Tool.” Journal of Molecular Biology 215 (3) (October 5): 
403–410. doi:10.1006/jmbi.1990.9999. 
Andreou, Alexandra, Florian Brodhun, and Ivo Feussner. 2009. “Biosynthesis of 
Oxylipins in Non-Mammals.” Progress in Lipid Research 48 (3-4) (July): 148–
170. doi:10.1016/j.plipres.2009.02.002. 
Basu, Samar. 2007. “Novel Cyclooxygenase-Catalyzed Bioactive Prostaglandin F2alpha 
from Physiology to New Principles in Inflammation.” Medicinal Research 
Reviews 27 (4) (July): 435–468. doi:10.1002/med.20098. 
Benecky, M J, J E Frew, N Scowen, P Jones, and B M Hoffman. 1993. “EPR and 
ENDOR Detection of Compound I from Micrococcus Lysodeikticus Catalase.” 
Biochemistry 32 (44) (November 9): 11929–11933. 
Berman, Helen, Kim Henrick, and Haruki Nakamura. 2003. “Announcing the 
Worldwide Protein Data Bank.” Nature Structural & Molecular Biology 10 (12) 
(December): 980–980. doi:10.1038/nsb1203-980. 
Bhattacharyya, D K, M Lecomte, C J Rieke, M Garavito, and W L Smith. 1996. 
“Involvement of Arginine 120, Glutamate 524, and Tyrosine 355 in the Binding 
of Arachidonate and 2-Phenylpropionic Acid Inhibitors to the Cyclooxygenase 
Active Site of Ovine Prostaglandin Endoperoxide H Synthase-1.” The Journal of 
Biological Chemistry 271 (4) (January 26): 2179–2184. 
Boeglin, W E, R B Kim, and A R Brash. 1998. “A 12R-Lipoxygenase in Human Skin: 
Mechanistic Evidence, Molecular Cloning, and Expression.” Proceedings of the 
National Academy of Sciences of the United States of America 95 (12) (June 9): 
6744–6749. 
	  114	  
Bowman, A S, J W Dillwith, and J R Sauer. 1996. “Tick Salivary Prostaglandins: 
Presence, Origin and Significance.” Parasitology Today (Personal Ed.) 12 (10) 
(October): 388–396. 
Bradford, James Richard. 2001. “Protein Design for Biopharmaceutical Development at 
GlaxoSmithKline”. The University of Leeds. 
http://bmbpcu36.leeds.ac.uk/prot_analysis/MRes_Dissertation.doc. 
Brash, A R. 1999. “Lipoxygenases: Occurrence, Functions, Catalysis, and Acquisition of 
Substrate.” The Journal of Biological Chemistry 274 (34) (August 20): 23679–
23682. 
Breder, C D, D Dewitt, and R P Kraig. 1995. “Characterization of Inducible 
Cyclooxygenase in Rat Brain.” The Journal of Comparative Neurology 355 (2) 
(May 1): 296–315. doi:10.1002/cne.903550208. 
Buczynski, Matthew W., Darren S. Dumlao, and Edward A. Dennis. 2009. “Thematic 
Review Series: Proteomics. An Integrated Omics Analysis of Eicosanoid 
Biology,” Journal of Lipid Research 50 (6) (June 1): 1015–1038. 
doi:10.1194/jlr.R900004-JLR200. 
Büyükgüzel, K, H Tunaz, S M Putnam, and D Stanley. 2002. “Prostaglandin 
Biosynthesis by Midgut Tissue Isolated from the Tobacco Hornworm, Manduca 
Sexta.” Insect Biochemistry and Molecular Biology 32 (4) (April): 435–443. 
Canutescu, Adrian A, Andrew A Shelenkov, and Roland L Dunbrack Jr. 2003. “A 
Graph-Theory Algorithm for Rapid Protein Side-Chain Prediction.” Protein 
Science: A Publication of the Protein Society 12 (9) (September): 2001–2014. 
doi:10.1110/ps.03154503. 
Carton, Yves, Francoise Frey, David W Stanley, Emily Vass, and Anthony J Nappi. 
2002. “Dexamethasone Inhibition of the Cellular Immune Response of 
Drosophila Melanogaster against a Parasitoid.” The Journal of Parasitology 88 
(2) (April): 405–407. doi:10.1645/0022-3395(2002)088[0405:DIOTCI]2.0.CO;2. 
Cashman, J R, D Hanks, and R I Weiner. 1987. “Epoxy Derivatives of Arachidonic Acid 
Are Potent Stimulators of Prolactin Secretion.” Neuroendocrinology 46 (3) 
(September): 246–251. 
Castresana, J. 2000. “Selection of Conserved Blocks from Multiple Alignments for 
Their Use in Phylogenetic Analysis.” Molecular Biology and Evolution 17 (4) 
(April 1): 540–552. 
Chen, Lan-Ying, Kikuko Watanabe, and Osamu Hayaishi. 1992. “Purification and 
Characterization of Prostaglandin F Synthase from Bovine Liver.” Archives of 
Biochemistry and Biophysics 296 (1) (July): 17–26. doi:10.1016/0003-
9861(92)90539-9. 
Cheng, H F, J L Wang, M Z Zhang, Y Miyazaki, I Ichikawa, J A McKanna, and R C 
Harris. 1999. “Angiotensin II Attenuates Renal Cortical Cyclooxygenase-2 
Expression.” The Journal of Clinical Investigation 103 (7) (April): 953–961. 
doi:10.1172/JCI5505. 
Cheng, J, A Z Randall, M J Sweredoski, and P Baldi. 2005. “SCRATCH: A Protein 
Structure and Structural Feature Prediction Server.” Nucleic Acids Research 33 
(Web Server issue) (July 1): W72–76. doi:10.1093/nar/gki396. 
	  115	  
Chintapalli, Venkateswara R., Jing Wang, and Julian A. T. Dow. 2007. “Using FlyAtlas 
to Identify Better Drosophila Melanogaster Models of Human Disease.” Nature 
Genetics 39 (6): 715–720. doi:10.1038/ng2049. 
Christopher, J, and B Axelrod. 1971. “On the Different Positional Specificities of 
Peroxidation of Linoleate Shown by Two Isozymes of Soybean Lipoxygenase.” 
Biochemical and Biophysical Research Communications 44 (3) (August 6): 731–
736. 
Cole, Christian, Jonathan D. Barber, and Geoffrey J. Barton. 2008. “The Jpred 3 
Secondary Structure Prediction Server.” Nucleic Acids Research 36 (suppl 2) 
(July 1): W197–W201. doi:10.1093/nar/gkn238. 
De Castro, Edouard, Christian J A Sigrist, Alexandre Gattiker, Virginie Bulliard, Petra S 
Langendijk-Genevaux, Elisabeth Gasteiger, Amos Bairoch, and Nicolas Hulo. 
2006. “ScanProsite: Detection of PROSITE Signature Matches and ProRule-
Associated Functional and Structural Residues in Proteins.” Nucleic Acids 
Research 34 (Web Server issue) (July 1): W362–365. doi:10.1093/nar/gkl124. 
Dean, Paul, Julia C Gadsden, Elaine H Richards, John P Edwards, A Keith Charnley, 
and Stuart E Reynolds. 2002. “Modulation by Eicosanoid Biosynthesis Inhibitors 
of Immune Responses by the Insect Manduca Sexta to the Pathogenic Fungus 
Metarhizium Anisopliae.” Journal of Invertebrate Pathology 79 (2) (February): 
93–101. 
DeLano, WL. 2002. “The PyMOL Molecular Graphics System.” http://www.pymol.org. 
Dereeper, A, V Guignon, G Blanc, S Audic, S Buffet, F Chevenet, J-F Dufayard, et al. 
2008. “Phylogeny.fr: Robust Phylogenetic Analysis for the Non-Specialist.” 
Nucleic Acids Research 36 (Web Server issue) (July 1): W465–469. 
doi:10.1093/nar/gkn180. 
Dietz, R, W Nastainczyk, and H H Ruf. 1988. “Higher Oxidation States of Prostaglandin 
H Synthase. Rapid Electronic Spectroscopy Detected Two Spectral Intermediates 
during the Peroxidase Reaction with Prostaglandin G2.” European Journal of 
Biochemistry / FEBS 171 (1-2) (January 15): 321–328. 
Downer, R G.H., S J. Moore, W L Diehl-Jones, and C A. Mandato. 1997. “The Effects 
of Eicosanoid Biosynthesis Inhibitors On Prophenoloxidase Activation, 
Phagocytosis and Cell Spreading in Galleria Mellonella.” Journal of Insect 
Physiology 43 (1) (February 19): 1–8. 
Dunford, H Brian. 1999. Heme Peroxidases. John Wiley New York: 
Edgar, Robert C. 2004. “MUSCLE: Multiple Sequence Alignment with High Accuracy 
and High Throughput.” Nucleic Acids Research 32 (5): 1792–1797. 
doi:10.1093/nar/gkh340. 
Eguchi, Y, N Eguchi, H Oda, K Seiki, Y Kijima, Y Matsu-ura, Y Urade, and O 
Hayaishi. 1997. “Expression of Lipocalin-Type Prostaglandin D Synthase (beta-
Trace) in Human Heart and Its Accumulation in the Coronary Circulation of 
Angina Patients.” Proceedings of the National Academy of Sciences of the 
United States of America 94 (26) (December 23): 14689–14694. 
Elmarakby, Ahmed A. 2012. “Reno-Protective Mechanisms of Epoxyeicosatrienoic 
Acids in Cardiovascular Disease.” American Journal of Physiology - Regulatory, 
Integrative and Comparative Physiology 302 (3) (February 1): R321–R330. 
doi:10.1152/ajpregu.00606.2011. 
	  116	  
Endo, Satoshi, Toshiyuki Matsunaga, Yukio Kitade, Satoshi Ohno, Kazuo Tajima, 
Ossama El-Kabbani, and Akira Hara. 2008. “Human Carbonyl Reductase 4 Is a 
Mitochondrial NADPH-Dependent Quinone Reductase.” Biochemical and 
Biophysical Research Communications 377 (4) (December 26): 1326–1330. 
doi:10.1016/j.bbrc.2008.11.003. 
Endo, T, F Ogushi, S Sone, T Ogura, Y Taketani, Y Hayashi, N Ueda, and S Yamamoto. 
1995. “Induction of Cyclooxygenase-2 Is Responsible for Interleukin-1 Beta-
Dependent Prostaglandin E2 Synthesis by Human Lung Fibroblasts.” American 
Journal of Respiratory Cell and Molecular Biology 12 (3) (March): 358–365. 
Eswar, Narayanan, Ben Webb, Marc A Marti-Renom, M S Madhusudhan, David 
Eramian, Min-Yi Shen, Ursula Pieper, and Andrej Sali. 2006. “Comparative 
Protein Structure Modeling Using Modeller.” Current Protocols in 
Bioinformatics / Editoral Board, Andreas D. Baxevanis ... [et Al Chapter 5 
(October): Unit 5.6. doi:10.1002/0471250953.bi0506s15. 
Falck, J R, S Manna, J Moltz, N Chacos, and J Capdevila. 1983. “Epoxyeicosatrienoic 
Acids Stimulate Glucagon and Insulin Release from Isolated Rat Pancreatic 
Islets.” Biochemical and Biophysical Research Communications 114 (2) (July 
29): 743–749. 
Ferguson, Andrew D, Brian M McKeever, Shihua Xu, Douglas Wisniewski, Douglas K 
Miller, Ting-Ting Yamin, Robert H Spencer, et al. 2007. “Crystal Structure of 
Inhibitor-Bound Human 5-Lipoxygenase-Activating Protein.” Science (New 
York, N.Y.) 317 (5837) (July 27): 510–512. doi:10.1126/science.1144346. 
Feussner, Ivo, and Claus Wasternack. 2002. “The Lipoxygenase Pathway.” Annual 
Review of Plant Biology 53 (1): 275–297. 
doi:10.1146/annurev.arplant.53.100301.135248. 
Finn, Robert D, Jaina Mistry, John Tate, Penny Coggill, Andreas Heger, Joanne E 
Pollington, O Luke Gavin, et al. 2010. “The Pfam Protein Families Database.” 
Nucleic Acids Research 38 (Database issue) (January): D211–222. 
doi:10.1093/nar/gkp985. 
Finn, Robert D., Jody Clements, and Sean R. Eddy. 2011. “HMMER Web Server: 
Interactive Sequence Similarity Searching.” Nucleic Acids Research 39 (suppl 2) 
(July 1): W29–W37. doi:10.1093/nar/gkr367. 
Forrest, G L, and B Gonzalez. 2000. “Carbonyl Reductase.” Chemico-Biological 
Interactions 129 (1-2) (December 1): 21–40. 
Funk, C D. 1996. “The Molecular Biology of Mammalian Lipoxygenases and the Quest 
for Eicosanoid Functions Using Lipoxygenase-Deficient Mice.” Biochimica et 
Biophysica Acta 1304 (1) (November 11): 65–84. 
Funk, Colin D. 2001. “Prostaglandins and Leukotrienes: Advances in Eicosanoid 
Biology.” Science 294 (5548) (November 30): 1871–1875. 
doi:10.2307/3085407. 
Gadelhak, G G, V K Pedibhotla, and D W Stanley-Samuelson. 1995. “Eicosanoid 
Biosynthesis by Hemocytes from the Tobacco Hornworm, Manduca Sexta.” 
Insect Biochemistry and Molecular Biology 25 (6) (June): 743–749. 
Gao, Ling, William E Zackert, Justin J Hasford, Michael E Danekis, Ginger L Milne, 
Catha Remmert, Jeff Reese, et al. 2003. “Formation of Prostaglandins E2 and D2 
via the Isoprostane Pathway: A Mechanism for the Generation of Bioactive 
	  117	  
Prostaglandins Independent of Cyclooxygenase.” The Journal of Biological 
Chemistry 278 (31) (August 1): 28479–28489. doi:10.1074/jbc.M303984200. 
Garavito, R Michael, and Anne M Mulichak. 2003. “The Structure of Mammalian 
Cyclooxygenases.” Annual Review of Biophysics and Biomolecular Structure 32: 
183–206. doi:10.1146/annurev.biophys.32.110601.141906. 
Garcia, Eloi S, Evandro M M Machado, and Patrícia Azambuja. 2004. “Effects of 
Eicosanoid Biosynthesis Inhibitors on the Prophenoloxidase-Activating System 
and Microaggregation Reactions in the Hemolymph of Rhodnius Prolixus 
Infected with Trypanosoma Rangeli.” Journal of Insect Physiology 50 (2-3) 
(March): 157–165. doi:10.1016/j.jinsphys.2003.11.002. 
García-Bueno, Borja, Jordi Serrats, and Paul E Sawchenko. 2009. “Cerebrovascular 
Cyclooxygenase-1 Expression, Regulation, and Role in Hypothalamic-Pituitary-
Adrenal Axis Activation by Inflammatory Stimuli.” The Journal of 
Neuroscience: The Official Journal of the Society for Neuroscience 29 (41) 
(October 14): 12970–12981. doi:10.1523/JNEUROSCI.2373-09.2009. 
Garscha, Ulrike, and Ernst H Oliw. 2009. “Leucine/valine Residues Direct Oxygenation 
of Linoleic Acid by (10R)- and (8R)-Dioxygenases: Expression and Site-
Directed Mutagenesis oF (10R)-Dioxygenase with Epoxyalcohol Synthase 
Activity.” The Journal of Biological Chemistry 284 (20) (May 15): 13755–
13765. doi:10.1074/jbc.M808665200. 
Gately, Stephen. 2000. “The Contributions of Cyclooxygenase-2 to Tumor 
Angiogenesis.” Cancer and Metastasis Reviews 19 (1-2) (June 1): 19–27. 
doi:10.1023/A:1026575610124. 
Geourjon, C, and G Deléage. 1995. “SOPMA: Significant Improvements in Protein 
Secondary Structure Prediction by Consensus Prediction from Multiple 
Alignments.” Computer Applications in the Biosciences: CABIOS 11 (6) 
(December): 681–684. 
Gerena, R L, D Irikura, Y Urade, N Eguchi, D A Chapman, and G J Killian. 1998. 
“Identification of a Fertility-Associated Protein in Bull Seminal Plasma as 
Lipocalin-Type Prostaglandin D Synthase.” Biology of Reproduction 58 (3) 
(March): 826–833. 
Gerlo, Sarah, Peggy Verdood, Birgit Gellersen, Elisabeth L Hooghe-Peters, and Ron 
Kooijman. 2004. “Mechanism of Prostaglandin (PG)E2-Induced Prolactin 
Expression in Human T Cells: Cooperation of Two PGE2 Receptor Subtypes, E-
Prostanoid (EP) 3 and EP4, via Calcium- and Cyclic Adenosine 5’-
Monophosphate-Mediated Signaling Pathways.” Journal of Immunology 
(Baltimore, Md.: 1950) 173 (10) (November 15): 5952–5962. 
Gerwick, W H. 1994. “Structure and Biosynthesis of Marine Algal Oxylipins.” 
Biochimica et Biophysica Acta 1211 (3) (March 24): 243–255. 
Gilbert, R S, S T Reddy, D A Kujubu, W Xie, S Luner, and H R Herschman. 1994. 
“Transforming Growth Factor Beta 1 Augments Mitogen-Induced Prostaglandin 
Synthesis and Expression of the TIS10/prostaglandin Synthase 2 Gene Both in 
Swiss 3T3 Cells and in Murine Embryo Fibroblasts.” Journal of Cellular 
Physiology 159 (1) (April): 67–75. doi:10.1002/jcp.1041590110. 
	  118	  
Gouet, P, E Courcelle, D I Stuart, and F Métoz. 1999. “ESPript: Analysis of Multiple 
Sequence Alignments in PostScript.” Bioinformatics (Oxford, England) 15 (4) 
(April): 305–308. 
Grad, Iwona, Thomas A McKee, Sara M Ludwig, Gary W Hoyle, Patricia Ruiz, 
Wolfgang Wurst, Thomas Floss, Charles A Miller 3rd, and Didier Picard. 2006. 
“The Hsp90 Cochaperone p23 Is Essential for Perinatal Survival.” Molecular 
and Cellular Biology 26 (23) (December): 8976–8983. doi:10.1128/MCB.00734-
06. 
Grechkin, A. 1998. “Recent Developments in Biochemistry of the Plant Lipoxygenase 
Pathway.” Progress in Lipid Research 37 (5) (November): 317–352. 
Groeger, Alison L, Chiara Cipollina, Marsha P Cole, Steven R Woodcock, Gustavo 
Bonacci, Tanja K Rudolph, Volker Rudolph, Bruce A Freeman, and Francisco J 
Schopfer. 2010. “Cyclooxygenase-2 Generates Anti-Inflammatory Mediators 
from Omega-3 Fatty Acids.” Nature Chemical Biology 6 (6) (June): 433–441. 
doi:10.1038/nchembio.367. 
Guindon, Stéphane, and Olivier Gascuel. 2003. “A Simple, Fast, and Accurate 
Algorithm to Estimate Large Phylogenies by Maximum Likelihood.” Systematic 
Biology 52 (5) (October): 696–704. 
Ha, Eun-Mi, Chun-Taek Oh, Ji-Hwan Ryu, Yun-Soo Bae, Sang-Won Kang, In-Hwan 
Jang, Paul T Brey, and Won-Jae Lee. 2005. “An Antioxidant System Required 
for Host Protection against Gut Infection in Drosophila.” Developmental Cell 8 
(1) (January): 125–132. doi:10.1016/j.devcel.2004.11.007. 
Hamberg, M, J Svensson, and B Samuelsson. 1975. “Thromboxanes: A New Group of 
Biologically Active Compounds Derived from Prostaglandin Endoperoxides.” 
Proceedings of the National Academy of Sciences of the United States of 
America 72 (8) (August): 2994–2998. 
Harris, Sarah G, Josue Padilla, Laura Koumas, Denise Ray, and Richard P Phipps. 2002. 
“Prostaglandins as Modulators of Immunity.” Trends in Immunology 23 (3) 
(March 1): 144–150. doi:10.1016/S1471-4906(01)02154-8. 
Hatae, Toshihisa, Shuntaro Hara, Chieko Yokoyama, Tomoko Yabuki, Hiroyasu Inoue, 
Volker Ullrich, and Ta-i Tanabe. 1996. “Site-Directed Mutagenesis of Human 
Prostacyclin Synthase: Alteration of Cys441 of the Cys-Pocket, and Glu347 and 
Arg350 of the EXXR Motif.” FEBS Letters 389 (3) (July 8): 268–272. 
doi:10.1016/0014-5793(96)00600-X. 
Hayaishi, O. 1991. “Molecular Mechanisms of Sleep-Wake Regulation: Roles of 
Prostaglandins D2 and E2.” FASEB Journal: Official Publication of the 
Federation of American Societies for Experimental Biology 5 (11) (August): 
2575–2581. 
Hayaishi, O, Y Urade, N Eguchi, and Z L Huang. 2004. “Genes for Prostaglandin D 
Synthase and Receptor as Well as Adenosine A2A Receptor Are Involved in the 
Homeostatic Regulation of Nrem Sleep.” Archives Italiennes de Biologie 142 (4) 
(July): 533–539. 
Hayes, J D, and R C Strange. 2000. “Glutathione S-Transferase Polymorphisms and 
Their Biological Consequences.” Pharmacology 61 (3) (September): 154–166. 
doi:28396. 
	  119	  
Hiller, Karsten, Max Schobert, Claudia Hundertmark, Dieter Jahn, and Richard Münch. 
2003. “JVirGel: Calculation of Virtual Two-Dimensional Protein Gels.” Nucleic 
Acids Research 31 (13) (July 1): 3862–3865. 
Hirokawa, T, S Boon-Chieng, and S Mitaku. 1998. “SOSUI: Classification and 
Secondary Structure Prediction System for Membrane Proteins.” Bioinformatics 
14 (4) (January 1): 378 –379. doi:10.1093/bioinformatics/14.4.378. 
Hofmann, K, and W Stoffel. 1993. “TMbase—a Database of Membrane Spanning 
Proteins Segments.” Biol. Chem. Hoppe-Seyler (347): 166. 
Holm, Peter J, Priyaranjan Bhakat, Caroline Jegerschöld, Nobuhiko Gyobu, Kaoru 
Mitsuoka, Yoshinori Fujiyoshi, Ralf Morgenstern, and Hans Hebert. 2006. 
“Structural Basis for Detoxification and Oxidative Stress Protection in 
Membranes.” Journal of Molecular Biology 360 (5) (July 28): 934–945. 
doi:10.1016/j.jmb.2006.05.056. 
Inoue, Tsuyoshi, Daisuke Irikura, Nobuo Okazaki, Shigehiro Kinugasa, Hiroyoshi 
Matsumura, Nobuko Uodome, Masaki Yamamoto, et al. 2003. “Mechanism of 
Metal Activation of Human Hematopoietic Prostaglandin D Synthase.” Nature 
Structural & Molecular Biology 10 (4) (April): 291–296. doi:10.1038/nsb907. 
Ishikawa, Tomo-O, Kevin J P Griffin, Utpal Banerjee, and Harvey R Herschman. 2007. 
“The Zebrafish Genome Contains Two Inducible, Functional Cyclooxygenase-2 
Genes.” Biochemical and Biophysical Research Communications 352 (1) 
(January 5): 181–187. doi:10.1016/j.bbrc.2006.11.007. 
Jakobsson, P J, S Thorén, R Morgenstern, and B Samuelsson. 1999. “Identification of 
Human Prostaglandin E Synthase: A Microsomal, Glutathione-Dependent, 
Inducible Enzyme, Constituting a Potential Novel Drug Target.” Proceedings of 
the National Academy of Sciences of the United States of America 96 (13) (June 
22): 7220–7225. 
Järving, Reet, Ivar Järving, Reet Kurg, Alan R Brash, and Nigulas Samel. 2004. “On the 
Evolutionary Origin of Cyclooxygenase (COX) Isozymes: Characterization of 
Marine Invertebrate COX Genes Points to Independent Duplication Events in 
Vertebrate and Invertebrate Lineages.” The Journal of Biological Chemistry 279 
(14) (April 2): 13624–13633. doi:10.1074/jbc.M313258200. 
Jegerschöld, Caroline, Sven-Christian Pawelzik, Pasi Purhonen, Priyaranjan Bhakat, 
Karina Roxana Gheorghe, Nobuhiko Gyobu, Kaoru Mitsuoka, Ralf Morgenstern, 
Per-Johan Jakobsson, and Hans Hebert. 2008. “Structural Basis for Induced 
Formation of the Inflammatory Mediator Prostaglandin E2.” Proceedings of the 
National Academy of Sciences of the United States of America 105 (32) (August 
12): 11110–11115. doi:10.1073/pnas.0802894105. 
Johnson, J. A., A. el Barbary, S. E. Kornguth, J. F. Brugge, and F. L. Siegel. 1993. 
“Glutathione S-Transferase Isoenzymes in Rat Brain Neurons and Glia.” The 
Journal of Neuroscience 13 (5) (May 1): 2013–2023. 
Jones, D A, D P Carlton, T M McIntyre, G A Zimmerman, and S M Prescott. 1993. 
“Molecular Cloning of Human Prostaglandin Endoperoxide Synthase Type II 
and Demonstration of Expression in Response to Cytokines.” The Journal of 
Biological Chemistry 268 (12) (April 25): 9049–9054. 
	  120	  
Jones, D T. 1999. “Protein Secondary Structure Prediction Based on Position-Specific 
Scoring Matrices.” Journal of Molecular Biology 292 (2) (September 17): 195–
202. doi:10.1006/jmbi.1999.3091. 
Kalajdzic, P., S. Oehler, M. Reczko, N. Pavlidi, J. Vontas, A.G. Hatzigeorgiou, and C. 
Savakis. 2012. “Use of Mutagenesis, Genetic Mapping and next Generation 
Transcriptomics to Investigate Insecticide Resistance Mechanisms.” PLoS ONE 
7 (6): e40296. 
Kanaoka, Yoshihide, Ko Fujimori, Reiko Kikuno, Yuriko Sakaguchi, Yoshihiro Urade, 
and Osamu Hayaishi. 2000. “Structure and Chromosomal Localization of Human 
and Mouse Genes for Hematopoietic Prostaglandin D Synthase.” European 
Journal of Biochemistry 267 (11): 3315–3322. doi:10.1046/j.1432-
1327.2000.01362.x. 
Kanost, Michael R, Haobo Jiang, and Xiao-Qiang Yu. 2004. “Innate Immune Responses 
of a Lepidopteran Insect, Manduca Sexta.” Immunological Reviews 198 (April): 
97–105. 
Karthein, R, R Dietz, W Nastainczyk, and H H Ruf. 1988. “Higher Oxidation States of 
Prostaglandin H Synthase. EPR Study of a Transient Tyrosyl Radical in the 
Enzyme during the Peroxidase Reaction.” European Journal of Biochemistry / 
FEBS 171 (1-2) (January 15): 313–320. 
Koljak, R, I Järving, R Kurg, W E Boeglin, K Varvas, K Valmsen, M Ustav, A R Brash, 
and N Samel. 2001. “The Basis of Prostaglandin Synthesis in Coral: Molecular 
Cloning and Expression of a Cyclooxygenase from the Arctic Soft Coral 
Gersemia Fruticosa.” The Journal of Biological Chemistry 276 (10) (March 9): 
7033–7040. doi:10.1074/jbc.M009803200. 
Koumas, Laura, and Richard P. Phipps. 2002. “Differential COX Localization and PG 
Release in Thy-1+ and Thy-1− Human Female Reproductive Tract Fibroblasts.” 
American Journal of Physiology - Cell Physiology 283 (2) (August 1): C599–
C608. doi:10.1152/ajpcell.00065.2002. 
Kraemer, S A, K A Arthur, M S Denison, W L Smith, and D L DeWitt. 1996. 
“Regulation of Prostaglandin Endoperoxide H Synthase-2 Expression by 
2,3,7,8,-Tetrachlorodibenzo-P-Dioxin.” Archives of Biochemistry and Biophysics 
330 (2) (June 15): 319–328. doi:10.1006/abbi.1996.0259. 
Krieg, P, A Kinzig, M Heidt, F Marks, and G Fürstenberger. 1998. “cDNA Cloning of a 
8-Lipoxygenase and a Novel Epidermis-Type Lipoxygenase from Phorbol Ester-
Treated Mouse Skin.” Biochimica et Biophysica Acta 1391 (1) (March 6): 7–12. 
Kulmacz, R J, and W E Lands. 1983. “Requirements for Hydroperoxide by the 
Cyclooxygenase and Peroxidase Activities of Prostaglandin H Synthase.” 
Prostaglandins 25 (4) (April): 531–540. 
Kulmacz, R J, R B Pendleton, and W E Lands. 1994. “Interaction between Peroxidase 
and Cyclooxygenase Activities in Prostaglandin-Endoperoxide Synthase. 
Interpretation of Reaction Kinetics.” The Journal of Biological Chemistry 269 
(8) (February 25): 5527–5536. 
Kurumbail, R G, A M Stevens, J K Gierse, J J McDonald, R A Stegeman, J Y Pak, D 
Gildehaus, et al. 1996. “Structural Basis for Selective Inhibition of 
Cyclooxygenase-2 by Anti-Inflammatory Agents.” Nature 384 (6610) 
(December 19): 644–648. doi:10.1038/384644a0. 
	  121	  
Landino, L M, B C Crews, J K Gierse, S D Hauser, and L J Marnett. 1997. “Mutational 
Analysis of the Role of the Distal Histidine and Glutamine Residues of 
Prostaglandin-Endoperoxide Synthase-2 in Peroxidase Catalysis, Hydroperoxide 
Reduction, and Cyclooxygenase Activation.” The Journal of Biological 
Chemistry 272 (34) (August 22): 21565–21574. 
Lands, William EM, and B Samuelsson. 1968. “Phospholipid Precursors of 
Prostaglandins.” Biochimica et Biophysica Acta (BBA)-Lipids and Lipid 
Metabolism 164 (2): 426–429. 
Leclerc, Patrick, Jordane Biarc, Mireille St-Onge, Caroline Gilbert, Andrée-Anne 
Dussault, Cynthia Laflamme, and Marc Pouliot. 2008. “Nucleobindin Co-
Localizes and Associates with Cyclooxygenase (COX)-2 in Human 
Neutrophils.” PloS One 3 (5): e2229. doi:10.1371/journal.pone.0002229. 
Ledwith, B J, C J Pauley, L K Wagner, C L Rokos, D W Alberts, and S Manam. 1997. 
“Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and 
Non-Tetradecanoylphorbol 12,13-Myristate-Type Tumor Promoters in 
Immortalized Mouse Liver Cells.” The Journal of Biological Chemistry 272 (6) 
(February 7): 3707–3714. 
Lee, Dong-Sun, Pierre Nioche, Mats Hamberg, and C S Raman. 2008. “Structural 
Insights into the Evolutionary Paths of Oxylipin Biosynthetic Enzymes.” Nature 
455 (7211) (September 18): 363–368. doi:10.1038/nature07307. 
Legler, Daniel F., Markus Bruckner, Edith Uetz-von Allmen, and Petra Krause. 2010. 
“Prostaglandin E2 at New Glance: Novel Insights in Functional Diversity Offer 
Therapeutic Chances.” The International Journal of Biochemistry & Cell Biology 
42 (2) (February): 198–201. doi:10.1016/j.biocel.2009.09.015. 
Letunic, Ivica, Tobias Doerks, and Peer Bork. 2009. “SMART 6: Recent Updates and 
New Developments.” Nucleic Acids Research 37 (Database issue) (January): 
D229–232. doi:10.1093/nar/gkn808. 
Lewis, R A, N A Soter, P T Diamond, K F Austen, J A Oates, and L J Roberts 2nd. 
1982. “Prostaglandin D2 Generation after Activation of Rat and Human Mast 
Cells with Anti-IgE.” Journal of Immunology (Baltimore, Md.: 1950) 129 (4) 
(October): 1627–1631. 
Liedtke, Andy J., AdegokeO. Adeniji, Mo Chen, Michael C. Byrns, Yi Jin, David W. 
Christianson, Lawrence J. Marnett, and Trevor M. Penning. 2013. “Development 
of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 
(Type 5 17?-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in 
Castrate-Resistant Prostate Cancer.” Journal of Medicinal Chemistry 56 (6) 
(March 28): 2429–2446. doi:10.1021/jm3017656. 
Lim, H, R A Gupta, W G Ma, B C Paria, D E Moller, J D Morrow, R N DuBois, J M 
Trzaskos, and S K Dey. 1999. “Cyclo-Oxygenase-2-Derived Prostacyclin 
Mediates Embryo Implantation in the Mouse via PPARdelta.” Genes & 
Development 13 (12) (June 15): 1561–1574. 
Lim, H, B C Paria, S K Das, J E Dinchuk, R Langenbach, J M Trzaskos, and S K Dey. 
1997. “Multiple Female Reproductive Failures in Cyclooxygenase 2-Deficient 
Mice.” Cell 91 (2) (October 17): 197–208. 
	  122	  
Loll, P J, D Picot, and R M Garavito. 1995. “The Structural Basis of Aspirin Activity 
Inferred from the Crystal Structure of Inactivated Prostaglandin H2 Synthase.” 
Nature Structural Biology 2 (8) (August): 637–643. 
Lovgren, Alysia Kern, Martina Kovarova, and Beverly H Koller. 2007. “cPGES/p23 Is 
Required for Glucocorticoid Receptor Function and Embryonic Growth but Not 
Prostaglandin E2 Synthesis.” Molecular and Cellular Biology 27 (12) (June): 
4416–4430. doi:10.1128/MCB.02314-06. 
Luong, C, A Miller, J Barnett, J Chow, C Ramesha, and M F Browner. 1996. 
“Flexibility of the NSAID Binding Site in the Structure of Human 
Cyclooxygenase-2.” Nature Structural Biology 3 (11) (November): 927–933. 
Lüthy, R, J U Bowie, and D Eisenberg. 1992. “Assessment of Protein Models with 
Three-Dimensional Profiles.” Nature 356 (6364) (March 5): 83–85. 
doi:10.1038/356083a0. 
Machado, Ednildo, Luc Swevers, Nadia Sdralia, Marcelo N Medeiros, Fernando G 
Mello, and Kostas Iatrou. 2007. “Prostaglandin Signaling and Ovarian Follicle 
Development in the Silkmoth, Bombyx Mori.” Insect Biochemistry and 
Molecular Biology 37 (8) (August): 876–885. doi:10.1016/j.ibmb.2007.04.003. 
Mancini, J A, D Riendeau, J P Falgueyret, P J Vickers, and G P O’Neill. 1995. 
“Arginine 120 of Prostaglandin G/H Synthase-1 Is Required for the Inhibition by 
Nonsteroidal Anti-Inflammatory Drugs Containing a Carboxylic Acid Moiety.” 
The Journal of Biological Chemistry 270 (49) (December 8): 29372–29377. 
Mannervik, B, and U H Danielson. 1988. “Glutathione Transferases--Structure and 
Catalytic Activity.” CRC Critical Reviews in Biochemistry 23 (3): 283–337. 
Marchler-Bauer, Aron, John B Anderson, Farideh Chitsaz, Myra K Derbyshire, Carol 
DeWeese-Scott, Jessica H Fong, Lewis Y Geer, et al. 2009. “CDD: Specific 
Functional Annotation with the Conserved Domain Database.” Nucleic Acids 
Research 37 (Database issue) (January): D205–210. doi:10.1093/nar/gkn845. 
Marnett, L J, S W Rowlinson, D C Goodwin, A S Kalgutkar, and C A Lanzo. 1999. 
“Arachidonic Acid Oxygenation by COX-1 and COX-2. Mechanisms of 
Catalysis and Inhibition.” The Journal of Biological Chemistry 274 (33) (August 
13): 22903–22906. 
Martinez Molina, Daniel, Said Eshaghi, and Pär Nordlund. 2008. “Catalysis within the 
Lipid Bilayer-Structure and Mechanism of the MAPEG Family of Integral 
Membrane Proteins.” Current Opinion in Structural Biology 18 (4) (August): 
442–449. doi:10.1016/j.sbi.2008.04.005. 
Martinez Molina, Daniel, Anders Wetterholm, Andreas Kohl, Andrew A McCarthy, 
Damian Niegowski, Eva Ohlson, Tove Hammarberg, Said Eshaghi, Jesper Z 
Haeggström, and Pär Nordlund. 2007. “Structural Basis for Synthesis of 
Inflammatory Mediators by Human Leukotriene C4 Synthase.” Nature 448 
(7153) (August 2): 613–616. doi:10.1038/nature06009. 
Mattila, Simo, Hannu Tuominen, John Koivukangas, and Frej Stenbäck. 2009. “The 
Terminal Prostaglandin Synthases mPGES-1, mPGES-2, and cPGES Are All 
Overexpressed in Human Gliomas.” Neuropathology 29 (2) (April): 156–165. 
doi:10.1111/j.1440-1789.2008.00963.x. 
Medzhitov, Ruslan, and Charles Janeway Jr. 2000. “Fly Immunity: Great Expectations.” 
Genome Biology 1 (1): reviews106.1–reviews106.4. 
	  123	  
Miller, J S, T Nguyen, and D W Stanley-Samuelson. 1994. “Eicosanoids Mediate Insect 
Nodulation Responses to Bacterial Infections.” Proceedings of the National 
Academy of Sciences of the United States of America 91 (26) (December 20): 
12418–12422. 
Miyata, A., S. Hara, C. Yokoyama, H. Inoue, V. Ullrich, and T. Tanabe. 1994. 
“Molecular Cloning and Expression of Human Prostacyclin Synthase.” 
Biochemical and Biophysical Research Communications 200 (3) (May 15): 
1728–1734. doi:10.1006/bbrc.1994.1652. 
Mizuno, K, S Yamamoto, and W E Lands. 1982. “Effects of Non-Steroidal Anti-
Inflammatory Drugs on Fatty Acid Cyclooxygenase and Prostaglandin 
Hydroperoxidase Activities.” Prostaglandins 23 (5) (May): 743–757. 
Möller, S, M D Croning, and R Apweiler. 2001. “Evaluation of Methods for the 
Prediction of Membrane Spanning Regions.” Bioinformatics (Oxford, England) 
17 (7) (July): 646–653. 
Morishima, I, Y Yamano, K Inoue, and N Matsuo. 1997. “Eicosanoids Mediate 
Induction of Immune Genes in the Fat Body of the Silkworm, Bombyx Mori.” 
FEBS Letters 419 (1) (December 8): 83–86. 
Morita, Ikuo, Melvin Schindler, Martha K. Regier, James C. Otto, Takamitsu Hori, 
David L. DeWitt, and William L. Smith. 1995. “Different Intracellular Locations 
for Prostaglandin Endoperoxide H Synthase-1 and −2.” Journal of Biological 
Chemistry 270 (18) (May 5): 10902–10908. doi:10.1074/jbc.270.18.10902. 
Moriuchi, Hiroshi, Noriko Koda, Emiko Okuda-Ashitaka, Hiromi Daiyasu, Kensuke 
Ogasawara, Hiroyuki Toh, Seiji Ito, David F. Woodward, and Kikuko Watanabe. 
2008. “Molecular Characterization of a Novel Type of Prostamide/Prostaglandin 
F Synthase, Belonging to the Thioredoxin-like Superfamily.” Journal of 
Biological Chemistry 283 (2) (January 11): 792–801. 
doi:10.1074/jbc.M705638200. 
Morris, Garrett M, David S Goodsell, Robert S Halliday, Ruth Huey, William E Hart, 
Richard K Belew, and Arthur J Olson. 1998. “Automated Docking Using a 
Lamarckian Genetic Algorithm and an Empirical Binding Free Energy 
Function.” Journal of Computational Chemistry 19 (14) (November 15): 1639–
1662. doi:10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-
JCC10>3.0.CO;2-B. 
Murakami, M, H Naraba, T Tanioka, N Semmyo, Y Nakatani, F Kojima, T Ikeda, et al. 
2000. “Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-
Associated Prostaglandin E2 Synthase That Acts in Concert with 
Cyclooxygenase-2.” The Journal of Biological Chemistry 275 (42) (October 20): 
32783–32792. doi:10.1074/jbc.M003505200. 
Murakami, Makoto, Karin Nakashima, Daisuke Kamei, Seiko Masuda, Yukio Ishikawa, 
Toshiharu Ishii, Yoshihiro Ohmiya, Kikuko Watanabe, and Ichiro Kudo. 2003. 
“Cellular Prostaglandin E2 Production by Membrane-Bound Prostaglandin E 
Synthase-2 via Both Cyclooxygenases-1 and -2.” The Journal of Biological 
Chemistry 278 (39) (September 26): 37937–37947. 
doi:10.1074/jbc.M305108200. 
Nakanishi, Masako, Vijay Gokhale, Emmanuelle J Meuillet, and Daniel W Rosenberg. 
2010. “mPGES-1 as a Target for Cancer Suppression: A Comprehensive Invited 
	  124	  
Review ‘Phospholipase A2 and Lipid Mediators.’” Biochimie 92 (6) (June): 660–
664. doi:10.1016/j.biochi.2010.02.006. 
Nakatani, Yoshihito, Yutaka Hokonohara, Shigeru Kakuta, Katsuko Sudo, Yoichiro 
Iwakura, and Ichiro Kudo. 2007. “Knockout Mice Lacking cPGES/p23, a 
Constitutively Expressed PGE2 Synthetic Enzyme, Are Peri-Natally Lethal.” 
Biochemical and Biophysical Research Communications 362 (2) (October 19): 
387–392. doi:10.1016/j.bbrc.2007.07.180. 
Narumiya, S, T Ogorochi, K Nakao, and O Hayaishi. 1982. “Prostaglandin D2 in Rat 
Brain, Spinal Cord and Pituitary: Basal Level and Regional Distribution.” Life 
Sciences 31 (19) (November 8): 2093–2103. 
Needleman, Philip, Amiram Raz, Mark S. Minkes, James A. Ferrendelli, and Howard 
Sprecher. 1979. “Triene Prostaglandins: Prostacyclin and Thromboxane 
Biosynthesis and Unique Biological Properties.” Proceedings of the National 
Academy of Sciences 76 (2) (February 1): 944–948. 
Negishi, M, Y Sugimoto, and A Ichikawa. 1995. “Molecular Mechanisms of Diverse 
Actions of Prostanoid Receptors.” Biochimica et Biophysica Acta 1259 (1) 
(October 26): 109–119. 
Nelson, D R, T Kamataki, D J Waxman, F P Guengerich, R W Estabrook, R Feyereisen, 
F J Gonzalez, M J Coon, I C Gunsalus, and O Gotoh. 1993. “The P450 
Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, 
Early Trivial Names of Enzymes, and Nomenclature.” DNA and Cell Biology 12 
(1) (February): 1–51. 
Node, K, Y Huo, X Ruan, B Yang, M Spiecker, K Ley, D C Zeldin, and J K Liao. 1999. 
“Anti-Inflammatory Properties of Cytochrome P450 Epoxygenase-Derived 
Eicosanoids.” Science (New York, N.Y.) 285 (5431) (August 20): 1276–1279. 
Node, K, X L Ruan, J Dai, S X Yang, L Graham, D C Zeldin, and J K Liao. 2001. 
“Activation of Galpha S Mediates Induction of Tissue-Type Plasminogen 
Activator Gene Transcription by Epoxyeicosatrienoic Acids.” The Journal of 
Biological Chemistry 276 (19) (May 11): 15983–15989. 
doi:10.1074/jbc.M100439200. 
Notredame, C, D G Higgins, and J Heringa. 2000. “T-Coffee: A Novel Method for Fast 
and Accurate Multiple Sequence Alignment.” Journal of Molecular Biology 302 
(1) (September 8): 205–217. doi:10.1006/jmbi.2000.4042. 
Oleksiak, Marjorie F, Shu Wu, Carol Parker, Wei Qu, Rachel Cox, Darryl C Zeldin, and 
John J Stegeman. 2003. “Identification and Regulation of a New Vertebrate 
Cytochrome P450 Subfamily, the CYP2Ps, and Functional Characterization of 
CYP2P3, a Conserved Arachidonic Acid epoxygenase/19-Hydroxylase.” 
Archives of Biochemistry and Biophysics 411 (2) (March 15): 223–234. 
Oppermann, U.C.T., G. Nagel, I. Belai, J.E. Bueld, S. Genti-Raimondi, J. Koolman, K.J. 
Netter, and E. Maser. 1998. “Carbonyl Reduction of an Anti-Insect Agent 
Imidazole Analogue of Metyrapone in Soil Bacteria, Invertebrate and Vertebrate 
Species.” Chemico-Biological Interactions 114 (3): 211–224. 
Otto, J C, and W L Smith. 1994. “The Orientation of Prostaglandin Endoperoxide 
Synthases-1 and -2 in the Endoplasmic Reticulum.” The Journal of Biological 
Chemistry 269 (31) (August 5): 19868–19875. 
	  125	  
———. 1996. “Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-
Trifluoro-3-(m-[125I]iodophenyl)diazirine as a Probe of Membrane Association 
and the Cyclooxygenase Active Site.” The Journal of Biological Chemistry 271 
(17) (April 26): 9906–9910. 
Park, Jean Y., Michael H. Pillinger, and Steven B. Abramson. 2006. “Prostaglandin E2 
Synthesis and Secretion: The Role of PGE2 Synthases.” Clinical Immunology 
119 (3) (June): 229–240. doi:10.1016/j.clim.2006.01.016. 
Patterson, W R, T L Poulos, and D B Goodin. 1995. “Identification of a Porphyrin Pi 
Cation Radical in Ascorbate Peroxidase Compound I.” Biochemistry 34 (13) 
(April 4): 4342–4345. 
Perrone, Giuseppe, Mariagiovanna Zagami, Vittorio Altomare, Cleonice Battista, Sergio 
Morini, and Carla Rabitti. 2007. “COX-2 Localization within Plasma Membrane 
Caveolae-like Structures in Human Lobular Intraepithelial Neoplasia of the 
Breast.” Virchows Archiv: An International Journal of Pathology 451 (6) 
(December): 1039–1045. doi:10.1007/s00428-007-0506-4. 
Petersen, Thomas Nordahl, Søren Brunak, Gunnar von Heijne, and Henrik Nielsen. 
2011. “SignalP 4.0: Discriminating Signal Peptides from Transmembrane 
Regions.” Nature Methods 8 (10): 785–786. doi:10.1038/nmeth.1701. 
Picot, D, P J Loll, and R M Garavito. 1994. “The X-Ray Crystal Structure of the 
Membrane Protein Prostaglandin H2 Synthase-1.” Nature 367 (6460) (January 
20): 243–249. doi:10.1038/367243a0. 
Pilbeam, C C, P M Fall, C B Alander, and L G Raisz. 1997. “Differential Effects of 
Nonsteroidal Anti-Inflammatory Drugs on Constitutive and Inducible 
Prostaglandin G/H Synthase in Cultured Bone Cells.” Journal of Bone and 
Mineral Research: The Official Journal of the American Society for Bone and 
Mineral Research 12 (8) (August): 1198–1203. 
doi:10.1359/jbmr.1997.12.8.1198. 
Pilbeam, C C, H Kawaguchi, Y Hakeda, O Voznesensky, C B Alander, and L G Raisz. 
1993. “Differential Regulation of Inducible and Constitutive Prostaglandin 
Endoperoxide Synthase in Osteoblastic MC3T3-E1 Cells.” The Journal of 
Biological Chemistry 268 (34) (December 5): 25643–25649. 
Pinzar, Elena, Masashi Miyano, Yoshihide Kanaoka, Yoshihiro Urade, and Osamu 
Hayaishi. 2000. “Structural Basis of Hematopoietic Prostaglandin D Synthase 
Activity Elucidated by Site-Directed Mutagenesis.” Journal of Biological 
Chemistry 275 (40) (October 6): 31239–31244. doi:10.1074/jbc.M000750200. 
Pollastri, Gianluca, and Aoife McLysaght. 2005. “Porter: A New, Accurate Server for 
Protein Secondary Structure Prediction.” Bioinformatics 21 (8) (April 15): 1719–
1720. doi:10.1093/bioinformatics/bti203. 
Pritchard, K A, Jr, M K O’Banion, J M Miano, N Vlasic, U G Bhatia, D A Young, and 
M B Stemerman. 1994. “Induction of Cyclooxygenase-2 in Rat Vascular Smooth 
Muscle Cells in Vitro and in Vivo.” The Journal of Biological Chemistry 269 
(11) (March 18): 8504–8509. 
Rådmark, O, and B Samuelsson. 2010. “Microsomal Prostaglandin E Synthase-1 and 5-
Lipoxygenase: Potential Drug Targets in Cancer.” Journal of Internal Medicine 
268 (1) (July): 5–14. doi:10.1111/j.1365-2796.2010.02246.x. 
	  126	  
Rimarachin, J A, J A Jacobson, P Szabo, J Maclouf, C Creminon, and B B Weksler. 
1994. “Regulation of Cyclooxygenase-2 Expression in Aortic Smooth Muscle 
Cells.” Arteriosclerosis and Thrombosis: A Journal of Vascular Biology / 
American Heart Association 14 (7) (July): 1021–1031. 
Robertson, R P. 1998. “Dominance of Cyclooxygenase-2 in the Regulation of Pancreatic 
Islet Prostaglandin Synthesis.” Diabetes 47 (9) (September): 1379–1383. 
Rocca, B, L M Spain, E Puré, R Langenbach, C Patrono, and G A FitzGerald. 1999. 
“Distinct Roles of Prostaglandin H Synthases 1 and 2 in T-Cell Development.” 
The Journal of Clinical Investigation 103 (10) (May 15): 1469–1477. 
doi:10.1172/JCI6400. 
Roos, K Lamar Turepu, and Daniel L Simmons. 2005. “Cyclooxygenase Variants: The 
Role of Alternative Splicing.” Biochemical and Biophysical Research 
Communications 338 (1) (December 9): 62–69. doi:10.1016/j.bbrc.2005.08.031. 
Rost, Burkhard, and Jinfeng Liu. 2003. “The PredictProtein Server.” Nucleic Acids 
Research 31 (13) (July 1): 3300–3304. 
Saisawang, Chonticha, Jantana Wongsantichon, and Albert J Ketterman. 2012. “A 
Preliminary Characterization of the Cytosolic Glutathione Transferase Proteome 
from Drosophila Melanogaster.” The Biochemical Journal 442 (1) (February 15): 
181–190. doi:10.1042/BJ20111747. 
Samuelsson, B. 1963. “Isolation and Identification of Prostaglandins from Human 
Seminal Plasma. 18. Prostaglandins and Related Factors.” The Journal of 
Biological Chemistry 238 (October): 3229–3234. 
Sanz, Ana, Juan Ignacio Moreno, and Carmen Castresana. 1998. “PIOX, a New 
Pathogen-Induced Oxygenase with Homology to Animal Cyclooxygenase.” The 
Plant Cell Online 10 (9) (September 1): 1523–1537. doi:10.1105/tpc.10.9.1523. 
Schneider, Claus, William E Boeglin, Jeffery J Prusakiewicz, Scott W Rowlinson, 
Lawrence J Marnett, Nigulas Samel, and Alan R Brash. 2002. “Control of 
Prostaglandin Stereochemistry at the 15-Carbon by Cyclooxygenases-1 and -2. A 
Critical Role for Serine 530 and Valine 349.” The Journal of Biological 
Chemistry 277 (1) (January 4): 478–485. doi:10.1074/jbc.M107471200. 
Schultz, J, F Milpetz, P Bork, and C P Ponting. 1998. “SMART, a Simple Modular 
Architecture Research Tool: Identification of Signaling Domains.” Proceedings 
of the National Academy of Sciences of the United States of America 95 (11) 
(May 26): 5857–5864. 
Schulz, C E, R Rutter, J T Sage, P G Debrunner, and L P Hager. 1984. “Mössbauer and 
Electron Paramagnetic Resonance Studies of Horseradish Peroxidase and Its 
Catalytic Intermediates.” Biochemistry 23 (20) (September 25): 4743–4754. 
Serhan, Charles N, Nan Chiang, and Thomas E Van Dyke. 2008. “Resolving 
Inflammation: Dual Anti-Inflammatory and pro-Resolution Lipid Mediators.” 
Nature Reviews. Immunology 8 (5) (May): 349–361. doi:10.1038/nri2294. 
Sharma, Narayan P, Liang Dong, Chong Yuan, Kathleen R Noon, and William L Smith. 
2010. “Asymmetric Acetylation of the Cyclooxygenase-2 Homodimer by 
Aspirin and Its Effects on the Oxygenation of Arachidonic, Eicosapentaenoic, 
and Docosahexaenoic Acids.” Molecular Pharmacology 77 (6) (June): 979–986. 
doi:10.1124/mol.109.063115. 
	  127	  
Shen, Hong-Bin, and Kuo-Chen Chou. 2007. “Signal-3L: A 3-Layer Approach for 
Predicting Signal Peptides.” Biochemical and Biophysical Research 
Communications 363 (2) (November 16): 297–303. 
doi:10.1016/j.bbrc.2007.08.140. 
Shen, Li Rong, Chao Qiang Lai, Xiang Feng, Laurence D Parnell, Jian Bo Wan, Jing D 
Wang, Duo Li, Jose M Ordovas, and Jing X Kang. 2010. “Drosophila Lacks C20 
and C22 PUFAs.” Journal of Lipid Research 51 (10) (October): 2985–2992. 
doi:10.1194/jlr.M008524. 
Shi, J, T L Blundell, and K Mizuguchi. 2001. “FUGUE: Sequence-Structure Homology 
Recognition Using Environment-Specific Substitution Tables and Structure-
Dependent Gap Penalties.” Journal of Molecular Biology 310 (1) (June 29): 
243–257. doi:10.1006/jmbi.2001.4762. 
Shimokawa, T, R J Kulmacz, D L DeWitt, and W L Smith. 1990. “Tyrosine 385 of 
Prostaglandin Endoperoxide Synthase Is Required for Cyclooxygenase 
Catalysis.” The Journal of Biological Chemistry 265 (33) (November 25): 
20073–20076. 
Shimokawa, T, and W L Smith. 1991. “Essential Histidines of Prostaglandin 
Endoperoxide Synthase. His-309 Is Involved in Heme Binding.” The Journal of 
Biological Chemistry 266 (10) (April 5): 6168–6173. 
Shindyalov, I N, and P E Bourne. 1998. “Protein Structure Alignment by Incremental 
Combinatorial Extension (CE) of the Optimal Path.” Protein Engineering 11 (9) 
(September): 739–747. 
Sigrist, Christian J A, Lorenzo Cerutti, Edouard de Castro, Petra S Langendijk-
Genevaux, Virginie Bulliard, Amos Bairoch, and Nicolas Hulo. 2010. 
“PROSITE, a Protein Domain Database for Functional Characterization and 
Annotation.” Nucleic Acids Research 38 (Database issue) (January): D161–166. 
doi:10.1093/nar/gkp885. 
Sigrist, Christian J A, Edouard De Castro, Petra S Langendijk-Genevaux, Virginie Le 
Saux, Amos Bairoch, and Nicolas Hulo. 2005. “ProRule: A New Database 
Containing Functional and Structural Information on PROSITE Profiles.” 
Bioinformatics (Oxford, England) 21 (21) (November 1): 4060–4066. 
doi:10.1093/bioinformatics/bti614. 
Simmons, Daniel L, Regina M Botting, and Timothy Hla. 2004. “Cyclooxygenase 
Isozymes: The Biology of Prostaglandin Synthesis and Inhibition.” 
Pharmacological Reviews 56 (3) (September): 387–437. doi:10.1124/pr.56.3.3. 
Simpson, Natalie E., W. Marcus Lambert, Renecia Watkins, Shah Giashuddin, S. Joseph 
Huang, Ellinor Oxelmark, Rezina Arju, et al. 2010. “High Levels of Hsp90 Co-
Chaperone p23 Promotes Tumor Progression and Poor Prognosis in Breast 
Cancer by Increasing Lymph Node Metastases and Drug Resistance.” Cancer 
Research 70 (21) (November 1): 8446–8456. doi:10.1158/0008-5472.CAN-10-
1590. 
Singh, Sharda P., Julia A. Coronella, Helen Beneš, Bruce J. Cochrane, and Piotr 
Zimniak. 2001. “Catalytic Function of Drosophila Melanogaster Glutathione S-
Transferase DmGSTS1-1 (GST-2) in Conjugation of Lipid Peroxidation End 
Products.” European Journal of Biochemistry 268 (10): 2912–2923. 
doi:10.1046/j.1432-1327.2001.02179.x. 
	  128	  
Sjogren, Tove, Johan Nord, Margareta Ek, Patrik Johansson, Gang Liu, and Stefan 
Geschwindner. 2013. “Crystal Structure of Microsomal Prostaglandin E2 
Synthase Provides Insight into Diversity in the MAPEG Superfamily.” 
Proceedings of the National Academy of Sciences of the United States of 
America 110 (10) (March 5): 3806–3811. doi:10.1073/pnas.1218504110. 
Smith, W L. 1989. “The Eicosanoids and Their Biochemical Mechanisms of Action.” 
Biochemical Journal 259 (2) (April 15): 315–324. 
Smith, W L, D L DeWitt, and R M Garavito. 2000. “Cyclooxygenases: Structural, 
Cellular, and Molecular Biology.” Annual Review of Biochemistry 69: 145–182. 
doi:10.1146/annurev.biochem.69.1.145. 
Smith, W L, R M Garavito, and D L DeWitt. 1996. “Prostaglandin Endoperoxide H 
Synthases (cyclooxygenases)-1 and -2.” The Journal of Biological Chemistry 
271 (52) (December 27): 33157–33160. 
Smith, W L, and W E Lands. 1972. “Oxygenation of Polyunsaturated Fatty Acids during 
Prostaglandin Biosynthesis by Sheep Vesicular Gland.” Biochemistry 11 (17) 
(August 15): 3276–3285. 
Smith, William L, Yoshihiro Urade, and Per-Johan Jakobsson. 2011. “Enzymes of the 
Cyclooxygenase Pathways of Prostanoid Biosynthesis.” Chemical Reviews 111 
(10) (October 12): 5821–5865. doi:10.1021/cr2002992. 
Smith, William L., and Robert C. Murphy. 2002. “Chapter 13 The Eicosanoids: 
Cyclooxygenase, Lipoxygenase, and Epoxygenase Pathways.” In Biochemistry 
of Lipids, Lipoproteins and Membranes, 4th Edition, Volume 36:341–371. 
Elsevier. http://www.sciencedirect.com/science/article/pii/S0167730602360150. 
Snyder, G D, P Yadagiri, and J R Falck. 1989. “Effect of Epoxyeicosatrienoic Acids on 
Growth Hormone Release from Somatotrophs.” The American Journal of 
Physiology 256 (2 Pt 1) (February): E221–226. 
Söding, Johannes, Andreas Biegert, and Andrei N Lupas. 2005. “The HHpred 
Interactive Server for Protein Homology Detection and Structure Prediction.” 
Nucleic Acids Research 33 (Web Server issue) (July 1): W244–248. 
doi:10.1093/nar/gki408. 
Spector, A. A. 2008. “Arachidonic Acid Cytochrome P450 Epoxygenase Pathway.” The 
Journal of Lipid Research 50 (Supplement) (December 19): S52–S56. 
doi:10.1194/jlr.R800038-JLR200. 
Spencer, A G, E Thuresson, J C Otto, I Song, T Smith, D L DeWitt, R M Garavito, and 
W L Smith. 1999. “The Membrane Binding Domains of Prostaglandin 
Endoperoxide H Synthases 1 and 2. Peptide Mapping and Mutational Analysis.” 
The Journal of Biological Chemistry 274 (46) (November 12): 32936–32942. 
Spencer, Andrew G., John W. Woods, Toshiya Arakawa, Irwin I. Singer, and William L. 
Smith. 1998. “Subcellular Localization of Prostaglandin Endoperoxide H 
Synthases-1 and -2 by Immunoelectron Microscopy.” Journal of Biological 
Chemistry 273 (16) (April 17): 9886–9893. doi:10.1074/jbc.273.16.9886. 
Sritunyalucksana, K, K Wongsuebsantati, M W Johansson, and K Söderhäll. 2001. 
“Peroxinectin, a Cell Adhesive Protein Associated with the proPO System from 
the Black Tiger Shrimp, Penaeus Monodon.” Developmental and Comparative 
Immunology 25 (5-6) (July): 353–363. 
	  129	  
Stanley, D. 2011. “Eicosanoids: Progress towards Manipulating Insect Immunity.” 
Journal of Applied Entomology 135 (7): 534–545. doi:10.1111/j.1439-
0418.2010.01612.x. 
Stanley, David. 2006. “Prostaglandins and Other Eicosanoids in Insects: Biological 
Significance.” Annual Review of Entomology 51: 25–44. 
doi:10.1146/annurev.ento.51.110104.151021. 
Stanley, David, Eric Haas, and Jon Miller. 2012. “Eicosanoids: Exploiting Insect 
Immunity to Improve Biological Control Programs.” Insects 3 (2): 492–510. 
Stanley, David, Jon Miller, and Hasan Tunaz. 2009. “Eicosanoid Actions in Insect 
Immunity.” Journal of Innate Immunity 1 (4) (June): 282–290. 
doi:10.1159/000210371. 
Stanley-Samuelson, D W, E Jensen, K W Nickerson, K Tiebel, C L Ogg, and R W 
Howard. 1991. “Insect Immune Response to Bacterial Infection Is Mediated by 
Eicosanoids.” Proceedings of the National Academy of Sciences of the United 
States of America 88 (3) (February 1): 1064–1068. 
Stanley-Samuelson, D W, and C L Ogg. 1994. “Prostaglandin Biosynthesis by Fat Body 
from the Tobacco Hornworm, Manduca Sexta.” Insect Biochemistry and 
Molecular Biology 24 (5) (May): 481–491. 
Stanley-Samuelson, David W. 1987. “PHYSIOLOGICAL ROLES OF 
PROSTAGLANDINS AND OTHER EICOSANOIDS IN INVERTEBRATES.” 
The Biological Bulletin 173 (1) (August 1): 92. 
Stanley-Samuelson, David W., Russell A. Jurenka, Colleen Cripps, Gary J. Blomquist, 
and Mertxe de Renobales. 1988. “Fatty Acids in Insects: Composition, 
Metabolism, and Biological Significance.” Archives of Insect Biochemistry and 
Physiology 9 (1): 1–33. doi:10.1002/arch.940090102. 
Stanley-Samuelson, DW, and W Loher. 1986. “Prostaglandins in Insect Reproduction.” 
Ann. Entomol. Soc. Am (79): 841–53. 
Strand, MR. 2008. “Insect Hemocytes and Their Role in Immunity.” In Insect 
Immunology, 25–47. Amsterdam: Elsevier. 
Sumitani, Kaname, Ryutaro Kamijo, Takahiko Toyoshima, Yuko Nakanishi, Kunio 
Takizawa, Masashi Hatori, and Masao Nagumo. 2001. “Specific Inhibition of 
Cyclooxygenase-2 Results in Inhibition of Proliferation of Oral Cancer Cell 
Lines via Suppression of Prostaglandin E2 Production.” Journal of Oral 
Pathology & Medicine 30 (1): 41–47. doi:10.1034/j.1600-0714.2001.300107.x. 
Suzuki-Yamamoto, Toshiko, Mikio Nishizawa, Motonari Fukui, Emiko Okuda-
Ashitaka, Tatsuya Nakajima, Seiji Ito, and Kikuko Watanabe. 1999. “cDNA 
Cloning, Expression and Characterization of Human Prostaglandin F Synthase.” 
FEBS Letters 462 (3) (December 3): 335–340. doi:10.1016/S0014-
5793(99)01551-3. 
Tanikawa, Naomi, Yoshihiro Ohmiya, Hiroaki Ohkubo, Katsuyuki Hashimoto, Kenji 
Kangawa, Masami Kojima, Seiji Ito, and Kikuko Watanabe. 2002. 
“Identification and Characterization of a Novel Type of Membrane-Associated 
Prostaglandin E Synthase.” Biochemical and Biophysical Research 
Communications 291 (4) (March 8): 884–889. doi:10.1006/bbrc.2002.6531. 
Tanioka, T, Y Nakatani, N Semmyo, M Murakami, and I Kudo. 2000. “Molecular 
Identification of Cytosolic Prostaglandin E2 Synthase That Is Functionally 
	  130	  
Coupled with Cyclooxygenase-1 in Immediate Prostaglandin E2 Biosynthesis.” 
The Journal of Biological Chemistry 275 (42) (October 20): 32775–32782. 
doi:10.1074/jbc.M003504200. 
Tanioka, Toshihiro, Yoshihito Nakatani, Tsuyoshi Kobayashi, Masafumi Tsujimoto, 
Sachiko Oh-ishi, Makoto Murakami, and Ichiro Kudo. 2003. “Regulation of 
Cytosolic Prostaglandin E2 Synthase by 90-kDa Heat Shock Protein.” 
Biochemical and Biophysical Research Communications 303 (4) (April 18): 
1018–1023. doi:10.1016/S0006-291X(03)00470-4. 
Tateson, J E, S Moncada, and J R Vane. 1977. “Effects of Prostacyclin (PGX) on Cyclic 
AMP Concentrations in Human Platelets.” Prostaglandins 13 (3) (March): 389–
397. 
Thibault, Stephen T, Matthew A Singer, Wesley Y Miyazaki, Brett Milash, Nicholas A 
Dompe, Carol M Singh, Ross Buchholz, et al. 2004. “A Complementary 
Transposon Tool Kit for Drosophila Melanogaster Using P and piggyBac.” 
Nature Genetics 36 (3) (March): 283–287. doi:10.1038/ng1314. 
Thompson, J D, D G Higgins, and T J Gibson. 1994. “CLUSTAL W: Improving the 
Sensitivity of Progressive Multiple Sequence Alignment through Sequence 
Weighting, Position-Specific Gap Penalties and Weight Matrix Choice.” Nucleic 
Acids Research 22 (22) (November 11): 4673–4680. 
Tokugawa, Y, I Kunishige, Y Kubota, K Shimoya, T Nobunaga, T Kimura, F Saji, et al. 
1998. “Lipocalin-Type Prostaglandin D Synthase in Human Male Reproductive 
Organs and Seminal Plasma.” Biology of Reproduction 58 (2) (February): 600–
607. 
Toolson, E. C., P. D. Ashby, R. W. Howard, and D. W. Stanley-Samuelson. 1994. 
“Eicosanoids Mediate Control of Thermoregulatory Sweating in the Cicada, 
Tibicen Dealbatus (Insecta: Homoptera).” Journal of Comparative Physiology B 
164 (4) (September): 278–285. doi:10.1007/BF00346443. 
Tootle, Tina L, and Allan C Spradling. 2008. “Drosophila Pxt: A Cyclooxygenase-like 
Facilitator of Follicle Maturation.” Development (Cambridge, England) 135 (5) 
(March): 839–847. doi:10.1242/dev.017590. 
Tootle, Tina L., Dianne Williams, Alexander Hubb, Rebecca Frederick, and Allan 
Spradling. 2011. “Drosophila Eggshell Production: Identification of New Genes 
and Coordination by Pxt.” PLoS ONE 6 (5) (May 26): e19943. 
doi:10.1371/journal.pone.0019943. 
Tsai, Ah-Lim, and Richard J Kulmacz. 2010. “Prostaglandin H Synthase: Resolved and 
Unresolved Mechanistic Issues.” Archives of Biochemistry and Biophysics 493 
(1) (January 1): 103–124. doi:10.1016/j.abb.2009.08.019. 
Tsujii, M, S Kawano, S Tsuji, H Sawaoka, M Hori, and R N DuBois. 1998. 
“Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells.” Cell 
93 (5) (May 29): 705–716. 
Ueno, Noriko, Yui Takegoshi, Daisuke Kamei, Ichiro Kudo, and Makoto Murakami. 
2005. “Coupling between Cyclooxygenases and Terminal Prostanoid Synthases.” 
Biochemical and Biophysical Research Communications 338 (1) (December 9): 
70–76. doi:10.1016/j.bbrc.2005.08.152. 
	  131	  
Ullrich, V. 2003. “Thoughts on Thiolate Tethering. Tribute and Thanks to a Teacher.” 
Archives of Biochemistry and Biophysics 409 (1) (January 1): 45–51. 
doi:10.1016/S0003-9861(02)00410-1. 
Urade, Y, K Kitahama, H Ohishi, T Kaneko, N Mizuno, and O Hayaishi. 1993. 
“Dominant Expression of mRNA for Prostaglandin D Synthase in 
Leptomeninges, Choroid Plexus, and Oligodendrocytes of the Adult Rat Brain.” 
Proceedings of the National Academy of Sciences of the United States of 
America 90 (19) (October 1): 9070–9074. 
Van der Donk, Wilfred A, Ah-Lim Tsai, and Richard J Kulmacz. 2002. “The 
Cyclooxygenase Reaction Mechanism.” Biochemistry 41 (52) (December 31): 
15451–15458. 
Van der Ouderaa, F J, M Buytenhek, D H Nugteren, and D A Van Dorp. 1977. 
“Purification and Characterisation of Prostaglandin Endoperoxide Synthetase 
from Sheep Vesicular Glands.” Biochimica Et Biophysica Acta 487 (2) (May 
25): 315–331. 
Vane, J R. 1971. “Inhibition of Prostaglandin Synthesis as a Mechanism of Action for 
Aspirin-like Drugs.” Nature: New Biology 231 (25) (June 23): 232–235. 
Varvas, Külliki, Ivar Järving, Reet Koljak, Karin Valmsen, Alan R. Brash, and Nigulas 
Samel. 1999. “Evidence of a Cyclooxygenase-Related Prostaglandin Synthesis in 
Coral THE ALLENE OXIDE PATHWAY IS NOT INVOLVED IN 
PROSTAGLANDIN BIOSYNTHESIS.” Journal of Biological Chemistry 274 
(15) (April 9): 9923–9929. doi:10.1074/jbc.274.15.9923. 
Vázquez, Martha, Rocío Rodríguez, and Mario Zurita. 2002. “A New Peroxinectin-like 
Gene Preferentially Expressed during Oogenesis and Early Embryogenesis in 
Drosophila Melanogaster.” Development Genes and Evolution 212 (11) 
(December): 526–529. doi:10.1007/s00427-002-0283-7. 
Vos, R M, and P J Van Bladeren. 1990. “Glutathione S-Transferases in Relation to Their 
Role in the Biotransformation of Xenobiotics.” Chemico-Biological Interactions 
75 (3): 241–265. 
Watanabe, Kikuko. 2002. “Prostaglandin F Synthase.” Prostaglandins & Other Lipid 
Mediators 68–69 (August): 401–407. doi:10.1016/S0090-6980(02)00044-8. 
Watanabe, Kikuko, Hiroaki Ohkubo, Haruki Niwa, Naomi Tanikawa, Noriko Koda, 
Seiji Ito, and Yoshihiro Ohmiya. 2003. “Essential 110Cys in Active Site of 
Membrane-Associated Prostaglandin E Synthase-2.” Biochemical and 
Biophysical Research Communications 306 (2) (June 27): 577–581. 
Watanabe, Koji, Chiyo Sugawara, Ayako Ono, Yasuhito Fukuzumi, Shoko Itakura, 
Masaaki Yamazaki, Hiroyuki Tashiro, Kazutoyo Osoegawa, Eiichi Soeda, and 
Touru Nomura. 1998. “Mapping of a Novel Human Carbonyl Reductase, CBR3, 
and Ribosomal Pseudogenes to Human Chromosome 21q22.2.” Genomics 52 (1) 
(August 15): 95–100. doi:10.1006/geno.1998.5380. 
Weaver, A J, W P Sullivan, S J Felts, B A Owen, and D O Toft. 2000. “Crystal Structure 
and Activity of Human p23, a Heat Shock Protein 90 Co-Chaperone.” The 
Journal of Biological Chemistry 275 (30) (July 28): 23045–23052. 
doi:10.1074/jbc.M003410200. 
Wermuth, B. 1981. “Purification and Properties of an NADPH-Dependent Carbonyl 
Reductase from Human Brain. Relationship to Prostaglandin 9-Ketoreductase 
	  132	  
and Xenobiotic Ketone Reductase.” Journal of Biological Chemistry 256 (3) 
(February 10): 1206–1213. 
Wermuth, B., K. M. Bohren, G. Heinemann, J. P. von Wartburg, and K. H. Gabbay. 
1988. “Human Carbonyl Reductase. Nucleotide Sequence Analysis of a cDNA 
and Amino Acid Sequence of the Encoded Protein.” Journal of Biological 
Chemistry 263 (31) (November 5): 16185–16188. 
White, D. M., D. D. Mikol, R. Espinosa, B. Weimer, M. M. Le Beau, and K. Stefansson. 
1992. “Structure and Chromosomal Localization of the Human Gene for a Brain 
Form of Prostaglandin D2 Synthase.” Journal of Biological Chemistry 267 (32) 
(November 15): 23202–23208. 
Wiederstein, Markus, and Manfred J Sippl. 2007. “ProSA-Web: Interactive Web Service 
for the Recognition of Errors in Three-Dimensional Structures of Proteins.” 
Nucleic Acids Research 35 (Web Server issue) (July): W407–410. 
doi:10.1093/nar/gkm290. 
Xie, W L, J G Chipman, D L Robertson, R L Erikson, and D L Simmons. 1991. 
“Expression of a Mitogen-Responsive Gene Encoding Prostaglandin Synthase Is 
Regulated by mRNA Splicing.” Proceedings of the National Academy of 
Sciences of the United States of America 88 (7) (April 1): 2692–2696. 
Yamada, Taro, Junichi Komoto, Kikuko Watanabe, Yoshihiro Ohmiya, and Fusao 
Takusagawa. 2005. “Crystal Structure and Possible Catalytic Mechanism of 
Microsomal Prostaglandin E Synthase Type 2 (mPGES-2).” Journal of 
Molecular Biology 348 (5) (May 20): 1163–1176. 
doi:10.1016/j.jmb.2005.03.035. 
Yamagata, K, K Matsumura, W Inoue, T Shiraki, K Suzuki, S Yasuda, H Sugiura, C 
Cao, Y Watanabe, and S Kobayashi. 2001. “Coexpression of Microsomal-Type 
Prostaglandin E Synthase with Cyclooxygenase-2 in Brain Endothelial Cells of 
Rats during Endotoxin-Induced Fever.” The Journal of Neuroscience: The 
Official Journal of the Society for Neuroscience 21 (8) (April 15): 2669–2677. 
Yamamoto, Kohji, Akifumi Higashiura, Mamoru Suzuki, Kosuke Aritake, Yoshihiro 
Urade, Nobuko Uodome, and Atsushi Nakagawa. 2013. “Crystal Structure of a 
Bombyx Mori Sigma-Class Glutathione Transferase Exhibiting Prostaglandin E 
Synthase Activity.” Biochimica et Biophysica Acta (BBA) - General Subjects 
1830 (6) (June): 3711–3718. doi:10.1016/j.bbagen.2013.02.021. 
Yamamoto, S, H Suzuki, and N Ueda. 1997. “Arachidonate 12-Lipoxygenases.” 
Progress in Lipid Research 36 (1) (March): 23–41. 
Yamashita, Makiko, Shoutaro Tsuji, Akihito Nishiyama, Quentin N Myrvik, Ruth Ann 
Henriksen, and Yoshimi Shibata. 2007. “Differential Subcellular Localization of 
COX-2 in Macrophages Phagocytosing Heat-Killed Mycobacterium Bovis 
BCG.” American Journal of Physiology. Cell Physiology 293 (1) (July): C184–
190. doi:10.1152/ajpcell.00346.2006. 
Yang, Jianyi, Ambrish Roy, and Yang Zhang. 2013. “BioLiP: A Semi-Manually Curated 
Database for Biologically Relevant Ligand-Protein Interactions.” Nucleic Acids 
Research 41 (Database issue) (January): D1096–1103. doi:10.1093/nar/gks966. 
Yokoyama, C, A Miyata, H Ihara, V Ullrich, and T Tanabe. 1991. “Molecular Cloning 
of Human Platelet Thromboxane A Synthase.” Biochemical and Biophysical 
Research Communications 178 (3) (August 15): 1479–1484. 
	  133	  
Yokoyama, C, and T Tanabe. 1989. “Cloning of Human Gene Encoding Prostaglandin 
Endoperoxide Synthase and Primary Structure of the Enzyme.” Biochemical and 
Biophysical Research Communications 165 (2) (December 15): 888–894. 
Yoshioka, T, H Inoue, T Kasama, Y Seyama, S Nakashima, Y Nozawa, and Y Hotta. 
1985. “Evidence That Arachidonic Acid Is Deficient in Phosphatidylinositol of 
Drosophila Heads.” Journal of Biochemistry 98 (3) (September): 657–662. 
Yuan, Chong, Caroline Jill Rieke, Gilad Rimon, Byron A Wingerd, and William L 
Smith. 2006. “Partnering between Monomers of Cyclooxygenase-2 
Homodimers.” Proceedings of the National Academy of Sciences of the United 
States of America 103 (16) (April 18): 6142–6147. 
doi:10.1073/pnas.0601805103. 
Yuan, Chong, Ranjinder S Sidhu, Dmitry V Kuklev, Yuji Kado, Masayuki Wada, Inseok 
Song, and William L Smith. 2009. “Cyclooxygenase Allosterism, Fatty Acid-
Mediated Cross-Talk between Monomers of Cyclooxygenase Homodimers.” The 
Journal of Biological Chemistry 284 (15) (April 10): 10046–10055. 
doi:10.1074/jbc.M808634200. 
Zamocky, Marcel, Christa Jakopitsch, Paul G Furtmüller, Christophe Dunand, and 
Christian Obinger. 2008. “The Peroxidase-Cyclooxygenase Superfamily: 
Reconstructed Evolution of Critical Enzymes of the Innate Immune System.” 
Proteins 72 (2) (August): 589–605. doi:10.1002/prot.21950. 
Zeldin, Darryl C. 2001. “Epoxygenase Pathways of Arachidonic Acid Metabolism.” 
Journal of Biological Chemistry 276 (39) (September 28): 36059–36062. 
doi:10.1074/jbc.R100030200. 
Zhang, Yang. 2008. “I-TASSER Server for Protein 3D Structure Prediction.” BMC 
Bioinformatics 9: 40. doi:10.1186/1471-2105-9-40. 
Zimmerman, D C, and B A Vick. 1973. “Lipoxygenase in Chlorella Pyrenoidosa.” 
Lipids 8 (5) (May): 264–266. 
 
 
 
 
